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* 
1. Introduction 
Ageing affects individuals and nations everywhere. But a precise definition of what 
ageing is cannot be provided easily with regard to health aspects, social conventions and 
lifestyles that are intertwined with the ageing process. As a first step, the AGIR project 
has attempted to describe this process in EU countries by observing as many dimensions 
as possible related to it. 
Under Work Package 1 (WP1) of the AGIR project, teams were asked to produce 
comprehensive data on population, mortality, longevity, life-courses and morbidity for 
as many EU countries as possible and the WP1 leader team (FEDEA) was asked to 
summarise and elaborate on these data in various ways. Data has come mostly from 
national sources and from the European Community Household Panel (ECHP), but we 
have also used data from the Human Mortality Database (www.mortality.org).
 1 Data 
has been arranged in a database in Excel format following the criteria explained below. 
It will be documented and made available once completely checked. The countries 
covered are Belgium, Denmark, Germany, Spain, Finland, France, Ireland (partially), 
Italy, Sweden and the United Kingdom. 
The five areas in which WP1 data have been divided are: 
•  Population – that is, the longest possible time series of historical and projected 
population (2050) data at 31 December by year gender and age (0 to 100 or more); 
annual number of births by gender is also specified. 
                                                 
* J. A. Herce and Namkee Ahn are based at FEDEA while R. Gènova is based at the Instituto de Salud 
Carlos III in Madrid. Joaquín Pereira, also based at the Instituto de Salud Carlos III, died before seeing 
the final version of this report and we wish to dedicate the best of our efforts to his memory. The authors 
wish to thank all WP1-AGIR team members and Terkel Christiansen for providing the data upon which 
this comparative analysis is based as well as for their comments during discussions. Thanks are also due 
to J. Mortensen and R. Sauto at CEPS for their help and encouragement. Only the authors are responsible 
for any shortcomings remaining in this version of the report. 
1 Most of the data comes from the national statistical offices of the countries included in this study, 
although the AGIR teams have been responsible for gathering, documenting and manipulating the raw 
data. Where needed, these data has been completed with data from the Human Mortality Database of 
University of California, Berkeley (USA), and Max Planck Institute for Demographic Research 
(Germany) (available at www.mortality.org or www.humanmortality.de). Finally, data from the database 
La conjoncture des pays développés en chiffres of the  Institut National d’Études Démographiques 
(available at http://www.ined.fr/bdd/demogr/#) has provided us with valuable data for all the countries 
included here. 2 | AHN, GÈNOVA, HERCE AND PEREIRA 
•  Mortality – mortality rates for the same years as previously noted, by gender, year 
of birth and age; complete life-tables are shown for both genders (survivors) for as 
many years (historical and projected) as possible. 
•  Longevity – are shown for the same years previously noted (projections where 
possible) with a series of longevity indicators by gender, including  
-  life expectancy at birth, at age 65 and at age 80; 
-  the record age (age of the oldest person who passed away in any given year); 
-  median duration (age at which only 50% of a generation is still alive);  
-  modal duration (age at which the largest number of theoretical mortalities 
occur); and 
-  life endurance (age at which 90% of a generation has passed away). 
•  Life-courses – indicators about these, year by year and by gender, include (average) 
age at which schooling ends, age at first job, age at leaving the parental 
home/emancipation, age at forming a first household (by first marriage or other 
reasons), age at first childbirth, age at widowhood, age at invalidity, age at 
retirement, life expectancy at 65 and health- or disability-adjusted life expectancy at 
age 65. 
•  Morbidity – survey data on self-perceived health status and disability by age and 
gender has also been gathered. 
Teams working on individual countries have produced a report on the data set available 
for these countries containing a detailed description of the data and a thorough 
elaboration of different indicators. Data have been made available to WP1 team leader 
(FEDEA). 
European and other Western countries, which completed their major demographic 
transition of the modern era well before the middle of the 20
th century, initiated almost 
without interruption a “second demographic transition” (van de Kaa, 1987) that has 
lasted for almost half a century. This second transition can be characterised by a sharp 
decline in fertility as a rapid change in lifestyles and family/work arrangements took 
place after the baby-boom after the Second World War. A pronounced population 
ageing trend is now on course in these nations so that the age structure of the population 
as well as any other indicators concerning basic individual and aggregate lifecycle 
landmarks display a dramatic change, which is most likely to continue in the coming 
decades. These trends, in turn, will trigger profound adaptation among individuals 
existing institutions, resulting in behavioural changes to cope with new challenges, risks 
and opportunities. 
In this report we summarise and compare the demographic experience of ten EU 
countries since the mid-20
th century on the basis of the detailed data gathered within the 
AGIR project of ENEPRI. Concerning demography, we are interested in population 
dynamics as defined by births and mortalities. We also deal in more detail with survival 
and longevity, as experienced in Europe in the last half century in order to ascertain 
whether an increase in the absolute limit to human life or, rather, the fact that more and 
more people reach extreme ages is what drives the current population ageing process. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 3 
Two other phenomena draw our interest when focusing on the circumstances among 
which ageing is taking place at present. On the one hand, there is the fact that typical 
life-courses in Western countries are witnessing seemingly contradictory developments 
concerning, for instance, life duration and early retirement or other lifecycle landmarks. 
On the other hand, and most importantly, there is the issue of how healthy and/or 
disability-free people live extra years as life expectancy increases. 
All these areas (populations, mortality, longevity, life-courses and morbidity) are 
extremely intertwined and their interactions happen within a context of uninterrupted 
economic and technological advancement with which the former also interact. Our aim 
thus is to identify, out of the abundant data on the areas just mentioned, those facts, 
patterns and trends that better characterise the demographic process of Western Europe 
during the last half century. 
We have organised this report into three major sections, after a short discussion on the 
bio-demographic aspects of ageing: demography (section 3), life-courses (section 4) and 
morbidity (section 5). These sections help to organise the summary description of our 
database and the discussion of the major findings and its comparative dimension. A 
final section 6 tries to tentatively answer some of the questions raised by merely putting 
together part of the data we have collected from separate sources. These questions can 
be summarised into three very relevant ones indeed: What does living longer mean? Is 
living longer and working less mutually compatible? Does living longer mean living 
better? It turns out, ironically, that how we define ageing depends on the answers we 
may give to these questions.
2 
2.  Bio-demographic aspects of ageing 
We are interested in bio-demography in as much as some of its definitions and methods 
provide insight for the prospective analysis of the economic consequences of ageing, 
namely, health and pensions expenditure and retirement decisions. We want in 
particular to explore the fact that individuals live longer and possibly in better health in 
order to, on the one hand, ascertain the prospects for longer active lives and, on the 
other, to push the arguments in favour of policies influencing balanced work/retirement 
decisions, renewed public programmes and pro-health related behaviours in Europe. 
Past developments, of course, are also of primary interest for us. 
This section is thus devoted to a very general discussion of the issues that recent bio-
demographic research has brought to the forefront. We do not restrict ourselves to those 
aspects immediately related to our objective under WP1. On the contrary, we think that 
a wider perspective will help us to draw a broader and more useful picture of the 
implications of present demographic trends for the labour market or the welfare state. 
                                                 
2 The word ‘ageing’ will be used throughout most of this report with its standard meaning concerning the 
increased average age of a given population, or of its aged-persons ratio computed at around age 65. 
Ageing, however, can be defined on the basis of a given general health and ability status of a 
representative individual, which would result in a completely different picture. Further content is given to 
this critical concept in the next section. 4 | AHN, GÈNOVA, HERCE AND PEREIRA 
Longevity and the limit to life 
As a result of continuous developments in public health, medical technology and care 
delivery protocols, individuals, on average, live longer and in better health. These 
developments, per se, would not raise the observed limit of human lives, but are actually 
allowing more and more individuals to approach this limit and yet we can count the 
number of those that have reached 120 years by the fingers of our hands, no one so far, 
since records have been kept, having lived longer than 122 years (and 164 days, Jeanne 
Calment, a French woman who in passed away in 1997). Whether genetic science 
developments would allow a significant portion of individuals to live longer than that 
limit is still a matter of discussion, but for some scholars the knowledge and the 
technology needed for that is already there. A matter of discussion is also whether a 
limit exists at all for human life. As for the present state of art on this issue, rather than 
an indefinite limit there would be an indeterminate or, simply said, unknown limit 
(Carey and Judge, 2001). Further increases of life expectancy depend mostly of lower 
mortality at very old ages (Vaupel, 2001). 
Different terms bear strong relationship with the term longevity, in particular the terms 
‘mortality’ and ‘senescence’. Mortality is the portion of individuals of age x that die 
before reaching age x+1. For Carey and Judge, “senescence is a product of natural 
selection in its competition between survival and reproduction” (Carey and Judge, 2001, 
p. 16) and accounts for the fact that mortality rates are related to (increase with) age. 
Evidence, even if scattered, of lower mortality rates at older ages, among not only 
insects but also among humans, puts into question the conventional definition of 
senescence and leads one to think that there is no limit to the human life. 
Longevity, finally, is the time span that separates birth and mortality of a given 
individual. It is currently measured through different indicators: i) life expectancy at 
birth, or after 30 days or at other ages; ii) life endurance, or age at which 90% of 
individuals in a given cohort have deceased, or median duration, if 50% limit is taken; 
iii) modal life duration, or age of the modal frequency in the distribution of mortalities 
in a given year; and iv) maximum duration of life, or record age; etc. These different 
measures of longevity, however, do not always move in the same direction. Life 
expectancy is currently preferred. 
Human longevity has many determinants and, to a certain extent, is influenced by 
evolution (Carey and Judge, 2001). Leaving aside biological and physiological 
determinants of longevity, three groups of factors immediately determine longevity: i) 
socio-economic factors (income, education), ii) physical fitness, sport and nutrition, and 
iii) alcohol and smoking. In addition, there seems to be a positive feed-back of higher 
longevity. As for genetically determined or hereditary longevity, fathers’ age at 
conception is negatively correlated with daughters’ longevity and fathers’ longevity has 
a non linear positive relationship with children’s longevity (Gavrilov and Gavrilova, 
2001), but a general hereditary pattern of longevity does not clearly emerges from the 
literature or, if at all, this literature shows a rather weak case for it (Carey and Judge, 
2001). Among other ‘established facts’, that of females living longer than males has 
been shown not to be necessarily always the case (insects or humans centuries ago). 
Increases in longevity, however measured, are the norm everywhere. Centenarians 
accounted for five in every million in 1960 in developed countries, and for 50 per BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 5 
million in 1990 (Kannisto, 1994). Since 1950, one can actually speak of an “explosion 
of centenarians”, particularly females. Higher longevity would rather be owing to 
compression of morbidity (rectangularisation of the survival curves) (Robine, 2001) at 
older ages than to an extension of the absolute limit of life. Local concentration of life 
duration around an old age (increasing with time) is also compatible with an increasing 
age of modal mortality as a result of a less-perceptible compression of morbidity. The 
issue here is to show clearly that greater longevity correlates with the concentration of 
the distribution of life duration around certain ages It seems that after removing certain 
causes of mortality from the data that concentration does not occur – individuals simply 
live longer owing to an overall improvement in morbidity. 
Morbidity 
Morbidity is a term difficult to define with precision as it tries to capture the many 
dimensions of sickness (illness, disability, handicap and other states of ill-health either 
physical, social or mental) (Murray and Chen, 1992). Given that continuous change in 
policies, medical research and practice, public health and other factors produce 
simultaneous changes in morbidity and mortality, advances in those fields should lead 
to less morbidity and to lover overall mortality. However, changing self-perceptions of 
morbidity by individuals or better measurements in observed morbidity have produced 
divergent evolutions in morbidity and mortality through time leading some scholars to 
characterise cases of increases in morbidity as statistical artefacts. 
On the other hand, the difficulty of disentangling the factors and biases behind the 
observed co-movements in morbidity (either perceived or observed) and mortality 
makes even more difficult to properly characterise ‘health transitions’ which without 
doubt have occurred in the past decades in both developed and developing countries. 
The nature of these health transitions is thus still unclear (Murray and Chen, 1992). 
Note that research on “epidemiologic transitions” (Omran, 1971) can produce rather 
clear-cut answers as for the varying causes of death at different ages with time, while 
research on “health transitions” (Murray and Chen, 1992) faces the much more 
challenging task of explaining changes in such an elusive concept as morbidity. In the 
words of Murray and Chen (1992), “Health transition is a ... concept ... meant to capture 
the changing pattern of morbidity and mortality, the socioeconomic determinants of 
such change, and the response of the health care system”. 
As we cannot dismiss every case of increased morbidity (self-assessed or diagnosed) as 
a mere artefact owing to the fact that people are either more aware of their health status 
or are better diagnosed about it, we should accept that it is actually possible to live 
longer and have poorer health although the conventional wisdom states that individuals 
are, almost everywhere, living longer and better from a wide health perspective (lower 
or improved morbidity). 
Life-courses 
As mortality declines and life expectancies at different ages increase, many other 
aspects of individual and collective life are affected by that. Changes in the duration, 
organisation and quality of life-courses have important implications for the labour 
market and the welfare state, for instance, increasing the capacity of individuals to a 6 | AHN, GÈNOVA, HERCE AND PEREIRA 
better performance in the labour market when adults or reducing their overall 
dependency upon the pension or health systems when they are older. 
Life-courses, from an economical point of view, may be coarsely divided into three 
phases: i) childhood and education, ii) active life in the labour market and iii) 
retirement. Of course, many other landmarks of an individual life (forming a household, 
parenthood, etc.) are relevant for interdisciplinary research, and we also note that even a 
significant proportion of individuals never transit through the labour market, but these 
three phases could capture these features adequately if we adopt proper conventions. 
Thus, for most individuals, one can locate the episodes forming an independent 
household for the first time and having a first child at the transition between phases i) 
and ii). One could equally adopt a household perspective to cope with the fact that some 
of its members do not work at all, etc. Average ages for this transition, as we shall see, 
have been steadily increasing in the last few decades in developed countries. 
Morbidity considerations, on the other hand, have historically set the transition age 
between phases (ii) and (iii) at 60 to 65 years, and have even given rise to the welfare 
state, more than one hundred years ago. At present, after a process of declining 
morbidity in the last decades, these considerations do not determine any more 
retirement ages that otherwise should be increasing. However, declining morbidity at 
pre and post-retirement ages opens a new window of opportunities both for individuals 
and for the welfare state. On the other hand, morbidity at older ages, of a type rarely 
experienced in the past, pose new problems for the health system. 
Disability-free life expectancy 
Once some form of morbidity is taken into account the analysis of how individuals 
perform the different tasks associated to different phases of their entire life-courses 
takes on different perspectives, disciplines other than demography (sociology, 
psychology and economics in particular) may greatly benefit from an interdisciplinary 
approach. 
Disability adjusted life expectancy (DALE) indices provide, among other purposes, a 
convenient way to combine morbidity and mortality measures into a single measure 
(Sullivan, 1971). Of course, morbidity is defined here in a limited way as there are 
many concepts of health that could be used to define a correspondingly large set of 
adjusted life expectancies (Robine et al, 1999 and 2001). Section 5 is devoted to a 
detailed discussion of this point. 
Health evolution: What is an ‘old’ person? 
One is old because he or she expects to live longer or because approaches old age? 
What is old age? Was being 65 in 1900 the same as being 65 in 2000? Of course not. 
But then, what is ageing? 
From an aggregated point of view, ageing is taken to consist in an increase of the aged 
dependency ratio, that is, the ratio of the number of persons aged 65 and more to the 
number of persons aged between 15 and 64. There are many reasons to stick to this 
simple ratio as an indicator of ageing of a given population. To start with, 65 is the legal 
retirement age in most social security schemes and also the upper limit to the statistical BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 7 
definition of working age population. This age has been used as a dividing criterion for 
more than one hundred years when hardly 25% of a representative generation reached 
that age and not precisely in a healthy state. Today almost 90% of a generation would 
pass that threshold showing a much better health. 
From an individual perspective, however, age cannot be treated apart from health status 
when it comes to the characterisation of ageing. Institutional arrangements classify 
individuals as aged persons once they reach, say, 65, which makes them eligible for 
benefits in cash or in kind from the welfare state. And yet overall health and activity 
status of different persons at that same age can vary enormously. 
On average, long-term health evolutions imply that ageing is, on effective terms, a much 
slower process than implied by simply fixing the dividing age at any particular level. 
However, finding a proper definition of what is effective ageing is not easy. 
3. Demographic  trends  in the EU since 1950 
Western populations, as it is well known, have experienced a considerable change in the 
last half century. In EU countries, with few exceptions, population has not ceased to 
increase albeit at lower and lower rates because of the resulting effect of two 
compensating driving forces, that is, fewer births and increased life years. To this 
balance, immigration has been contributing on the plus side in most countries. Of 
course, each country has experienced different population dynamics, basically owing to 
different timing in their baby-booms and intensity of immigration flows, but all of them 
are now witnessing a considerable ‘ageing’ of their populations – a process that will 
change to higher gears in the coming decades. 
3.1 Population 
Table 1 shows population figures (first column) and derived population indicators for 
ten EU countries and selected years 1950, 1975 and 2000. It can be seen that population 
growth has diminished everywhere although countries such as France or the United 
Kingdom have succeeded in keeping a relatively high population growth through 
sustained fertility and immigration whereas Spain has most recently experienced high 
immigration flows and Ireland has both kept high fertility and reversed migration flows. 
Although in a typical year, everywhere, more boys are born than girls, the different 
mortality probabilities that affect each group cause that with few exceptions the gender 
balance in a given population tips towards the female side. This is apparent in Table 1 
(third column) in the four largest countries of the EU, although Nordic countries and 
Ireland have kept in the last decades a closer balance among genders that has been 
nevertheless tipping recently towards the more standard female bias (Figure 3). 
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Table 1. Population indicators for (selected) EU countries 1950-2000 
 Year 
Total 
population 
(a) 
Annual 
Population
growth 
(%) 
Females 
to males 
ratio 
Support 
ratio (b) 
Aged 
Ratio (c) 
Average 
age 
1950 8,645 0.30 1.033 6.10 11.12  35.45 
1975 9,807 0.24 1.043 4.59 13.96  35.82  Belgium 
2000  10,263  0.24 1.045 3.89 16.85  39.30 
1950 4,252 0.96 1.016 7.24  8.96 32.54 
1975 5,055 0.38 1.019 4.83 13.26  35.40  Denmark 
2000 5,368 0.36 1.023 4.50 14.83  38.76 
1950  69,346  0.63 1.170 6.90  9.73 34.64 
1975 78,465 -0.53  1.109  4.26  14.97 36.56  Germany 
2000 82,038 -0.15  1.054  4.17  16.32 40.36 
1950  30,583       
1975  35,813  1.11 1.044 5.91 10.52  32.68  Spain 
2000  40,122  0.98 1.043 4.04 16.93  39.35 
1950 3,986 1.31 0.988 9.61  6.64 29.74 
1975 4,720 0.22 0.974 6.26 10.77  33.95  Finland 
2000 5,181 0.19 1.007 4.46 15.00  38.88 
1950  41,614  0.87 1.081 5.83 11.36  34.81 
1975  52,606  0.55 1.041 4.67 13.40  34.52  France 
2000  58,754  0.41 1.054 4.18 15.61  37.79 
1950 2,961 -0.31 0.965       
1975 2,978 8.21 0.991 5.20 11.08  31.67  Ireland 
2000 3,787 1.51 1.014 5.99 11.16  34.54 
1950  47,516  0.53 1.043 8.01  8.20 31.48 
1975  55,293  0.66 1.047 5.34 11.93  34.50  Italy 
2000  57,680  0.12 1.060 3.76 17.97  40.86 
1950 6,978 0.91 1.009 6.58 10.14  34.36 
1975 8,193 0.39 1.011 4.10 15.69  37.74  Sweden 
2000 8,872 0.16 1.023 3.64 17.71  40.26 
1950  50,490  0.70 1.083 6.13 10.93  35.19 
1975 56,231 -0.01  1.056  4.44  14.13 35.97 
United 
Kingdom 
2000  59,756  0.43 1.028 4.20 15.59  38.32 
(a)  As of 31 December, in thousands 
(b)  Number of persons of between 15 and 64 years of age per person of 65 or more. 
(c)  Number of persons of 65 or more per 100 persons of any age. 
Note. Data in this table come from the following sources: national statistical offices (provided by the AGIR-
WP1 teams), INED (www.ined.fr/bdd/demogr/) and the Human Mortality Database [University of California, 
Berkeley (US) and Max Planck Institute for Demographic Research (Germany). Available at 
www.mortality.org or www.humanmortality.de (data downloaded on May 2003)]. 
 
As for total population, Figure 1 shows more eloquently how in general population size 
has been growing less rapidly since 1975 after when the oil crisis almost stopped 
migration flows and fertility started to decline dramatically. More recently, many BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 9 
European Union countries have been experiencing intense immigration flows, which 
has resulted in a stimulus to population growth, as can be seen in Figure 2. 
Figure 1. Total population of (selected) EU countries 1950-2000 
(as of 31 December, x1000) 
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Source: Table 1. 
Figure 2. Population growth of (selected) EU countries 1950-2000 (in %) 
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Source: Table 1. 
Figure 3. Females to males ratio in (selected) EU countries 1950-2000 
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The dynamics of total population hides, however, the dramatic developments that have 
been the norm in EU countries concerning the age structure of the population. Table 1 
(columns fourth to sixth) shows three of these indicators: the ‘support ratio’, which is 
the inverse of the aged dependency ratio, the ‘aged (persons) ratio’ and the average age 
of the population.
3  
Two different trends can be observed around these indicators, which are also pictured 
separately in Figures 4 to 6. 
Support ratios diminished appreciably everywhere between 1950 and 1975. That is, the 
number of persons of working age to those aged 65 or more fell from six to between 
four and five, and fell again between 1975 and 2000 to around four. In countries such as 
Belgium, Sweden and Italy this ratio is now well below four, whereas in Ireland it has 
increased to a very high level of six.  
 
Figure 4. Support ratio in (selected) EU countries 1950-2000 
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Source: Table 1 (see Table 1 also for definition). 
 
Ageing however, has advanced in a different and more mixed fashion as can be seen in 
Figure 5. With the exception of Ireland, the share of persons aged 65 and more in total 
population has doubled from around eight (with a large variance, however) in 1950 till 
now. This development has been more rapid in the 1960s and 1970s than afterwards in 
Denmark, Germany, Sweden or the United Kingdom whereas in the rest of the countries 
considered the pace has been more regular and particularly intense during the last 25 
years in Italy or Spain. Ireland has hardly experienced that kind of ageing in the recent 
decades. 
                                                 
3 See notes to Table 1 for definitions. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 11 
 
Figure 5. Aged ratio in (selected) EU countries 1950-2000 (in %) 
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Source: Table 1 (see Table 1 also for definition). 
 
When we define ageing through average age of the population, we observe that it has 
been happening particularly since 1975. In 1950, average age of the population in most 
countries stayed around 33.5 years, increased to almost 35 years in 1975 and more than 
doubled this increase in the period 1975-2000 to reach at almost 39 years observed at 
present. This is probably the single best indicator of how a given population ages 
through time in the sense expressed before that ageing is just getting older in terms of 
pure age. 
Figure 6. Average age of the population in (selected) EU countries 1950-2000 
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Source: Table 1. 
 
Whereas age ratios may have a more complex dynamics depending on the cutting age at 
which the line is drawn, average age computations give every age the corresponding 
cohort weight and thus captures in a continuous fashion the passage of generations of 
different age. We will come back later to this point when discussing population 
projections. 
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3.2  Births and fertility 
Setting apart migrations, which we are not considering in this report, births and 
mortalities determine the natural movement of populations. Both developments have 
suffered dramatic changes in EU countries since 1950.  
Clearly, the demographic transition that Western countries initiated in the first half of 
the 20
th century has been unparalleled by the developments since 1950, but what has 
been different is the fact that fertility rates fell below replacement levels around 1970. 
This development holds the key to the aggregate population ageing process that will 
accelerate in the near decades in European Union countries, although unexpected 
changes in mortality will undoubtedly continue to affect ageing in the longer term. 
Table 2 shows the absolute numbers of births and derived indicators for our ten EU 
countries in 1950, 1975 and 2000. Most countries initiated their baby-booms just after 
World War II and finished them around 1970 (first column). Almost in every country 
male births exceeded female ones by about 5.5% and the evidence shows that this fact is 
became an even stronger profile in a majority of countries (third column, and Figure 9).  
Birth rates suffered in that period most of their decline and nearly stabilised afterwards 
(second column). Fertility rates, correspondingly, also fell below the replacement level 
around 1970 (fourth column). 
Figure 7 allows a closer look with regard to differences between countries. Of course, 
the absolute numbers of births tell us immediately about ‘large’ and ‘small’ countries in 
the European Union in terms of population, but above all tell us about the timing of the 
birth-booms in every country.  
Belgium Germany, Finland, France and the United Kingdom had ended their booms 
well before 1975 keeping afterwards stable number of total births. Spain initiated its 
baby-boom in the mid-1960s and ended it after 1975 to start a fast decline in fertility, 
which almost halved the size of new born cohorts in less than 20 years. Italy too has 
followed a similar pattern of recent decline in fertility although joined the European 
Union baby-boom just described much earlier. Two groups of fertility transitions can 
thus be discerned: fertility drops before 1975 in every country but in Italy, Spain and 
Ireland. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 13 
Table 2. Births and fertility indicators for (selected) EU countries 1950-2000 
 Year  Births  Birth rate
(a) 
Males to 
females 
ratio 
Fertility 
rate 
1950 145,672 16.85  1.055  2.34 
1975 119,693 12.20  1.059  1.74  Belgium 
2000 114,883 11.19  1.048  1.66 
1950 79,558 18.71 1.049  2.57 
1975 72,071 14.26 1.044  1.92  Denmark 
2000 67,081 12.59 1.055  1.77 
1950 1,116,701 16.10  1.074  2.1 
1975 782,310 9.97  1.061  1.48  Germany 
2000 770,744 9.38  1.058  1.36 
1950 565,378 20.11  1.055  2.48 
1975 669,378 18.69  1.072  2.80  Spain 
2000 397,632 9.91  1.071  1.24 
1950 98,065 24.60 1.055  3.16 
1975 65,719 13.92 1.060  1.68  Finland 
2000 56,742 10.95 1.064  1.73 
1950 862,310 20.60  1.051  2.93 
1975 745,065 14.10  1.051  1.93  France 
2000 726,768 13.20  1.055  1.89 
1950  63,565  21.4  3.41 
1975  67,178  21.7  3.43  Ireland 
2000  54,239  14.4  1.89 
1950 908,622 18.12  1.058  2.5 
1975 827,852 14.97  1.061  2.17  Italy 
2000 538,999 9.34  1.064  1.23 
1950 115,414 16.5  1.070  2.28 
1975 103,632 12.65  1.057  1.77  Sweden 
2000 90,441 10.19 1.064  1.54 
1950 818421 16.2  1.062   
1975 697,518 12.40  1.062  1.81  United Kingdom 
2000 679,029 11.4  1.053  1.65 
(a)  Number of births per 1000 population 
Note. Data in this table come from the following sources: national statistical offices (provided 
by the AGIR-WP1 Teams), INED (http://www.ined.fr/bdd/demogr/) and the Human Mortality 
Database [University of California, Berkeley (USA) and Max Planck Institute for 
Demographic Research (Germany). Available at www.mortality.org or 
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Figure 7. Total births in (selected) EU countries 1950-2000 
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Source: Table 2. 
 
Around 1950, birth rates were well above 15 births per thousand inhabitants with 
countries such as Spain, Finland, France and Ireland above the level of 20. Fifty years 
later, birth rates in most countries stand around ten per thousand with the exception of 
France and Ireland, which are closer to 15 rather. Again, in most countries, the larger 
part of this development happened before 1975 except in Spain, Ireland and Italy, where 
it took place mostly in recent decades. 
Figure 8. Birth rate in (selected) EU countries 1950-2000 
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Source: Table 2 (see also Table for definition). 
 
Everywhere male births exceed female ones by between 5% and 7%, despite the fact 
that within the whole population women are more numerous than men owing to gender 
related mortality risks. Although not everywhere, this gap has been growing steadily in 
the last 50 years. The exceptions, among the countries considered, are Belgium, 
Germany, Sweden and the United Kingdom (Figure 9). 
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Figure 9. Male vs. female births in (selected) EU countries 1950-2000 (in %) 
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Source: Table 2. 
 
The sharpest differences however can be seen when comparing fertility ratios. Again, in 
almost every country the fertility ratios fell from an (unweighted) average level of 2.5 in 
1950 to 2.0 in 1975 (just below the replacement level) to 1.6 in 2000. What seems a 
steady decline however hides the fact that countries such as Spain and Ireland kept or 
even increased their fertility rates all through the 1950-1975 period while the rest 
actually decreased their fertility rates rapidly in the same period. In Spain and Italy, the 
fertility rate bottomed at nearly one child per woman during the 1990s. Again, the 
Spanish, Irish and Italian cases explain the fall in average fertility for the whole group in 
the 1975-2000 period since fertility rates did not change much in the rest of the 
countries. 
Figure 10. Fertility ratio in (selected) EU countries 1950-2000 
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Source: Table 2. 
 
3.3 Mortality 
Falling mortality rate has been, jointly with lower fertility, the driving force of the 
demographic transition that has taken place in Western Europe since the 1950s. While 
fertility rates more or less stabilised during the last two decades, mortality rate continues 
to diminish everywhere at almost all ages. Mortality is measured in different ways. 16 | AHN, GÈNOVA, HERCE AND PEREIRA 
Measured as the number of mortalities per thousand in the population or the mortality 
rate, mortality could go up as population grows older simply because of a composition 
effect thus hiding more genuine developments. In this section we will approach the 
clear-cut phenomenon of falling mortality looking first at observed mortality risks by 
age and its evolution through time and later we will analyse survival probabilities 
computed for different EU countries out of their respective life tables. 
Until up to the 1960s, falling infant mortality was the mayor cause of longer survival 
among individuals. More recently increased survival at high or even extreme ages has 
taken the lead. Even since 1975 observed mortality risk at almost any age has fallen by 
a significant amount everywhere. We compute this risk as the number of observed 
mortalities of given age over total population of that age in any particular year. 
However, in order to make meaningful comparisons between countries and through time 
we use the ratio between observed risks at two extreme years in a given period of time 
(2000 vs. 1975) to summarise in a single indicator. Table 3 shows this ratio computed 
for nine EU countries and selected ages and Figure 11 displays the age profile of this 
ratio. Remember that a value of, say, 0.7 for the ratio at age 17 means that the mortality 
probability of an individual of that age has fallen in 2000 down to a 70% of its value in 
1975. In particular, it can be seen that in the last 25 years, infant mortality risk has fallen 
in most EU countries to a third of what it was in 1975, or that adult mortality risk (ages 
20 to 50) has fallen in the same period by between 30% and 35%. Mortality risk at 
higher ages (60 to 80) has fallen even more than at middle-age reaching nearly 60% of 
its level in 1975. 
Table 3. Mortality risk in 2000 relative to its value in 1975 for selected ages – EU countries 
 B  DK  D  E  F  FIN  IT  SW  UK  Average
0  0.30 0.45 0.24 0.23 0.36 0.38 0.24 0.40 0.43 0.32 
5  0.18 0.22 0.23 0.39 0.40 0.36 0.43 0.26 0.37 0.29 
10  0.39 0.44 0.43 0.50 0.46 0.49 0.47 0.36 0.54 0.45 
20  0.74 0.54 0.52 0.79 0.57 0.87 0.88 0.75 0.73 0.68 
30  0.72 0.70 0.42 0.77 0.85 0.74 0.96 0.50 0.99 0.69 
40  0.70 0.73 0.66 0.85 0.72 0.66 0.67 0.45 0.78 0.67 
50  0.73 0.80 0.53 0.66 0.68 0.67 0.57 0.56 0.64 0.64 
60  0.55 0.71 0.40 0.64 0.72 0.63 0.59 0.67 0.63 0.60 
70  0.53 0.87 0.51 0.59 0.60 0.59 0.74 0.63 0.67 0.62 
80  0.59 0.81 0.41 0.60 0.63 0.63 0.93 0.67 0.70 0.63 
Source: Own computations based on data from national statistical offices completed with data from 
www.mortality.org. 
 
Figure 11 allows a better perspective of the age pattern of the mortality risk ratios for 
each country. It is apparent that major gains have been the norm at ages below 10 and 
between 50 and 80. At extreme ages, computations lack precision owing to the rarity of 
cases to be dealt with, but from the figure we can infer that as age increases gains in 
decreased mortality risk become smaller and smaller. This is an indication of very 
limited ‘expansion’ of human life at extreme ages whereas the observed gains at ages 50 
to 80 is strong evidence of ‘compression’ of the survival curve. In other words, 
populations age not because the observed limit to human life increases, but because 
more and more people reach extreme ages. | 17 
Figure 11. Mortality risk in 2000 vs. mortality risk in 1975 for EU countries (a value of 1 means no change) 
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Source: Own computations based on data from national statistical offices completed with data from www.mortality.org. 
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At low ages, improvements in survival seem to have been impressive in the last 
decades, but one has to take into account the fact that at 1975 infant mortality was 
already very low. It was even lower at ages between 25 and 34 and thus improvements 
in survival have been more modest although some noticeable gains can be documented. 
It has been at ages between 50 and 80 where survival gains can be interpreted as 
impressive given the relatively large mortality risk affecting people of those ages in 
1975. 
Countries where gains of the sort described above have taken place in a more marked 
way are Germany, Finland and Sweden, while Denmark, the United Kingdom and Italy 
have performed more poorly on this account. Spain or Belgium have had mixed results 
performing below average (fewer gains) at ages until 45 and above average (more 
gains) after that age. 
Survivors 
The significant gains in mortality have also had a parallel development in what concerns 
the increase of persons of ages above 50 years everywhere. We have used the life tables 
of EU countries, available many of them since mid past century, to compute a simple 
ratio of theoretical survivors (out of a generation of 100,000 individuals of both 
genders) of any age in 2000 with respect to the survivors at same ages in 1975 or 1950, 
given data availability. These ratios are shown in Table 4 and in Figure 12 for selected 
ages. 
Table 4. Survivors ratio (2000 vs. 1975 or 1950) by selected age – EU countries 
  Ratios 2000 vs. 1950  Ratios 2000 vs. 1975 
 B  DK  D 
(West)  F SW  Average E  FI IT  UK  Average 
1 1.03  1.03 1.04 1.05  1.02  1.03 1.01 1.01 1.02  1.01  1.01 
10 1.06 1.03 1.04  1.06 1.02  1.04  1.02 1.01 1.02  1.01  1.01 
20 1.07 1.04 1.05  1.07 1.03  1.05  1.02 1.01 1.02  1.01  1.02 
30 1.08 1.04 1.06  1.08 1.04  1.06  1.02 1.02 1.03  1.01  1.02 
40 1.10 1.05 1.07  1.09 1.05  1.07  1.02 1.02 1.03  1.01  1.02 
50 1.14 1.06 1.08  1.13 1.06  1.09  1.03 1.04 1.04  1.02  1.03 
60 1.21 1.08 1.13  1.20 1.11  1.15  1.06 1.08 1.08  1.05  1.07 
70 1.40 1.15 1.27  1.39 1.24  1.29  1.14 1.22 1.16  1.12  1.16 
80 1.95 1.46 1.87  2.08 1.75  1.82  1.44 1.56 1.40  1.23  1.41 
90 3.84 3.18 4.75  5.17 4.02  4.19  2.42 2.55 2.25  1.43  2.16 
100 6.83 15.31 21.33 14.32 14.25 14.41    3.15 7.74    5.44 
Note. Ratios computed at extreme ages should be interpreted with caution given the small numbers on 
which their computation is based. 
Source: Own computations based on data from national statistical offices completed with data from 
www.mortality.org. 
 
Given that mortality risk is typically low at ages below 60, even significant decreases do 
not make the number of survivors to increase dramatically. In fact below that age, it is 
hard to see that survivors of a typical generation born today would increase above 10 
(20%) of those estimated for a typical generation born 25 (50) years ago. As time goes 
by, improvements at those ages would naturally become less and less relevant. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 19 
Nevertheless, above 60 years of age, the survivors’ ratio may still increase dramatically. 
Fifty years ago, typically, only 30% of a theoretical generation was expected to be alive 
at age 80. For a generation born today up to 60% of its members could reach that age. 
This means a factor of 2, or a factor of 4 for age 90, and so on. Of course, as we 
approach the age limit of a human life, the ratio would collapse. This is what Figure 12 
tells us rather eloquently. 
Figure 12. Survivors in 2000 vs. survivors in 1975 or 1950 for EU countries 
(theoretical generations) 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 20 | AHN, GÈNOVA, HERCE AND PEREIRA 
After certain ages the survivors’ ratio increases in an exponential way, even through 
more recent periods. Again, of course, the fact that more and more people survive close 
to the age limit, means that one should not expect any further dramatic increase in 
survivors’ ratios in the coming decades unless we consider the very high ages. Yet, the 
coming decades could witness similar developments in what concerns survival at very 
high ages to those seen in the recent past, even in a conventional scenario. France, 
Belgium and (West) Germany have pioneered, in general, these developments. 
 
3.4 Longevity 
After having looked at mortality and survival developments in EU countries during the 
last few decades, we turn to the description and analysis of various indicators of 
longevity. Representative individuals in Western countries live longer and longer as it is 
well documented through the data so far discussed in this report. Moreover, it is also 
apparent that so far rather than a higher age limit of human life, what causes the ageing 
of the population is the fact that more and more people reach extreme ages below that 
limit. 
There are a number of ways in which we can approach longevity, that is, the growing in 
ages of representative individuals. One important corollary of the causes of population 
ageing discussed before is that the distribution of the duration of individual life for the 
members of a given generation is becoming more ‘egalitarian’ with the extreme case 
being all members of a theoretical generation living exactly until the limiting age. This, 
however, as discussed before, is still far from being the case. 
In order to discuss this issue as documented from the data gathered under the AGIR 
project, we have obtained several measures of longevity. These are presented and 
defined in Table 5 and Figures 13 to 18. In order to provide a compact presentation, 
Table 5 only shows selected years, whilst each graph refers to one indicator at a time for 
those same selected years except Figure 18 that refers to the whole period 1950-2000 
for record age. It has been argued already that more and more people reach extreme 
ages. Thus the discussion in this section is a bit different and refers to the evolution of 
those extreme ages irrespective of the number of people that reach them. 
The most generally accepted measure of longevity is life expectancy, at birth or at later 
ages. It can be seen in Table 5 that this indicator has not ceased to increase during the 
last decades everywhere. Nevertheless this indicator, like most of those we will define 
later on, is computed out of life tables for theoretical generations born in any year. 
There is no apparent deceleration in this trend for, on average, life expectancy has 
increased by five years for every 25 years of time. 
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Table 5. Longevity indicators 1950-2000 – EU countries 
 Year 
Life 
expectancy
at birth (a)
Median 
duration 
(b) 
Modal 
duration 
(c) 
Life 
endurance 
(d) 
Record 
Age 
(e) 
1950 67.4 73.4  76  87.0   
1975 72.5 76.1  79  88.7  106  Belgium 
2000 78.3 81.7  86  93.1  110 
1950 70.3 75.3  77  87.3  102 
1975 74.1 77.5  82  90.4  108  Denmark 
2000 76.8 79.5  80  92.3  110 
1950 66.6 74.0  77  86.0   
1975 71.5 76.0  79  88.0  107  Germany 
2000 77.9 81.0  83  93.0  112 
1950       
1975 73.4 77.5  79  89.4  109  Spain 
2000 79.1 82.6  87  93.4  110 
1950         101 
1975 71.9 75.5  78  88.4  107  Finland 
2000 77.7 81.2  85  92.4  110 
1950 66.4 73.0  78  86.7  107 
1975 72.9 76.9  82  89.8  108  France 
2000 78.5 82.3  87  93.9  122 
1950         104 
1975 72.6 76.0  81  88.0  108  Italy 
2000 78.6 81.0  82  92.5  110 
1950 71.1 75.6  80  87.5  105 
1975 75.0 78.3  82  90.3  109  Sweden 
2000 79.7 82.6  86  93.4  110 
1950       
1975 74.6 78.1  83  90.4  110 
United 
Kingdom 
2000 77.9 81.8  84  90.6  115 
(a)  Average number of years that an individual born in a particular year is expected to live. 
(b)  Age at which 50% of the generation numbers born in a given year will remain alive 
(c)  Age at which the maximum number of mortalities of a generation born in a particular year 
would occur (excluding infant mortality) 
(d)  Age at which 10% of the generation numbers born in a given year will remain alive 
(e)  Highest age among observed mortalities in a given year 
Sources: Own computations based on data from national statistical offices completed with data from 
www.mortality.org. 
 
Figure 13 shows Sweden and Spain to have the highest life expectancies at birth (in 
2000) and Denmark, Finland and the UK to have the lowest. Progress on that account 
has also been pronounced during the 1980s and 1990s in most European Union 
countries. Of course, this development does not means that in the future life 
expectancies would augment as rapidly as in the past, for as the absolute limit of a 
human life remains unchanged, one should expect less and less margin to be left for 
further increases. Nevertheless, this absolute limit is not well known; yet if were we to 
place it at around 120 years of age, there still remains a considerable term before life 22 | AHN, GÈNOVA, HERCE AND PEREIRA 
expectancies show a clearly decelerating pattern. It is against this general background 
that most of the longevity indicators can be discussed, whose description follows. 
Figure 13. Life expectancy at birth (years) 1950, 1975 and 2000 for EU countries 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 
 
A typical generation born in 1950 in Western European countries would have exhausted 
half its numbers at age 74 or, put differently, individuals of that generation reaching 
their 74
th birthday would amount to half those born 74 years before. This is known as 
the ‘median duration’ of a given generation. For a generation born in 1975, the 
corresponding age is estimated to be about three years higher than for the 1950 birth 
cohort and almost four years higher for the birth cohort 2000 with respect to the 1975 
cohort. This can be seen for different EU countries in Figure 14. 
Again, these are theoretical estimates rather than observed ones since all these cohorts 
are still young. All in all they show that survival, as discussed before, is improving 
considerably at mature ages. Median duration, on average, has been growing faster in 
the recent decades than earlier almost everywhere. 
Figure 14. Median duration (age) 1950, 1975 and 2000 for EU countries 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 
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Almost as marked seems to have been the evolution of a more demanding indicator of 
generational duration – which is ‘life endurance’, where the survival limit is 10% of a 
given generation. The average age at which this limit is trespassed has risen from 87 
years of age in 1950 to 89.5 in 1975 and again to 92.5 in 2000 on average for those 
countries where data has been available to the AGIR teams – a further indication of 
(mildly) accelerated compression at the high end of the survivors’ line. This can be seen 
in Figure 15, where the cases of Belgium and Germany, on the one hand and Denmark, 
on the other, stand at the extremes whereas France (reckon the ages involved) clearly 
shows a considerable relative compression of its survival pattern. 
Figure 15. Life endurance (age) 1950, 1975 and 2000 for EU countries 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 
 
Also based on life tables, the age at which most of the theoretical motalities (excluding 
infant mortalities) happen in a given generation, so-called ‘modal duration’ has been 
steadily growing in the last decades. This can be seen in Figure 16 where the same 
pattern of acceleration could be observed but for few exceptions.  
It has to be said that this age can be very volatile as theoretical mortalities are after all 
based on one year observed mortalities whose numbers can be affected by many 
different circumstances. Nevertheless, modal duration stood near 78 years of age in 
1950, rose to slightly above 80 in 1975 and lies close to 85 years in 2000. 
Coming now to observed mortalities, a suggestive indicator, albeit fraught with 
problems when it comes to actual value concerning average longevity, is the age of the 
oldest person dead in any year. This is called the ‘record age’ and, of course, varies 
enormously for only a handful of individuals, often just one, even in large countries, 
happen to reach that very extreme. 24 | AHN, GÈNOVA, HERCE AND PEREIRA 
Figure 16. Modal duration (age) 1950, 1975 and 2000 for EU countries 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 
 
Record ages for EU countries are shown in Figure 17 either for 1950-2000 or 1975-
2000 and can be seen to have grown everywhere. France holds the record (in 1997) with 
Jeane Calment dead at 122. On average, record age has increased from 104 years in 
1950 (roughly the same as in 1900) to 108 in 1975 and 110 in 2002. The later figure, 
however, is biased downwards by the fact that available mortality records in many 
countries collapse at age ‘110 or plus’ thus biasing the whole average. 
As said before, just a handful of individuals reach the highest age recorded at mortality 
in every country, but the number of centenarians is increasing rapidly year after year in 
every country. Yet it would be simply wrong to infer from the above estimates of record 
ages that the age limit for a human being is actually increasing, let alone to provide the 
answer to the ‘million euro question’: What is the age limit for a human life? 
Figure 17. Record age 1950, 1975 and 2000 for EU countries 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 
 
All the previously discussed indicators of longevity can be put together as rough EU 
averages for the period to 2000, as done in Figure 18. All in all, only progress in 
longevity can be observed to the last fifty years in Europe. Indeed, although the BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 25 
dramatic developments achieved prior to 1950 seemed to have left only a small margin 
for further improvements, gains have been happening nevertheless at steady if not faster 
pace during the second half of the 20
th century. 
Figure 18. Measuring longevity in the EU from 1950 to 2000 
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Source: Own computations based on data from national statistical offices completed with data 
from www.mortality.org. 
 
4. Life-courses 
One of the aims of the team in charge of gathering demographic data within the AGIR 
project was to initiate the collection of data on what we have termed life-courses, that is, 
those landmarks in a typical life cycle that mark the passage from one state to another, 
for instance, from school to the labour market, or from work to inactivity. One can think 
of quite a large set of such landmarks and we have chosen those shown in Figure 19. 
Given that we were not able to collect data for all countries and all years, the averages 
have been computed only for the countries with data available. 
Further, it has to be taken into account that we are not talking about true cohorts when 
discussing about how different indicators relate to each other in any particular year. In 
fact, the figures discussed at a particular moment in time refer to strictly different 
generations. Those events happen to representative individuals of the concerned age that 
obviously do not belong to the same generation. If at all we could see the whole set of 
landmarks shown at any particular year as descriptive of a synthetic or theoretical 
generation.  
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Figure 19. Life-courses in the EU – 1950 to 2000 
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Source: Own computations based on data from national statistical offices and Eurostat, also 
completed with data from www.mortality.org. 
 
The story Figure 19 tells is as follows. Irrespective of gender, Europeans have been 
leaving school at higher ages, finding their first job later and thus leaving their parents’ 
home or getting married for the first time at later ages as well. They have, 
correspondingly, had their first babies at higher and higher ages. So far, this meant 
delayed entering into activity and household formation. 
Once in the labour force and effectively working, as it is well known, effective working 
periods have been far from being continuous for many workers across Europe, owing to 
unemployment spells. Near retirement, invalidity and other pre-retirement have 
increasingly prevented a significant share of the workforce from working while 
retirement through old-age has shown a slightly declining trend around the age of 60.  
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Together with delayed entrance in the labour market, unemployment, pre-retirement 
through invalidity or workforce adjustments and declining old age retirement have 
meant increasingly reduced effective work spans for the average worker in the last 
decades. 
After retirement, individuals and household face a totally different life span. 
Widowhood intervenes typically several years after retirement, at younger ages for 
women than for men, and the age at widowhood has increased substantially from at 
around the age of 65 in 1980 to almost 70 years nowadays. On average, life expectancy 
at 65 years (both genders) has also increased from ten more years in 1950 to 18 more 
years of life at present. 
Nevertheless, that considerably enlarged post-retirement span cannot be said to be free 
of troubles, for roughly the second half of it will be marked by some sort of health 
problem for the average individual as indicated by the ‘health adjusted life 
expectancies’ or HALE indicators that we have computed out of the European 
Community Household Panel. Focusing on ‘disability adjusted life expectancy’ or 
DALE, we find that, on average, even if these impairments would typically subtract less 
years to the total remaining life span after age 65 than general health troubles, the 
available data suggests an increased absolute morbidity due to disability. We explain 
below how these adjusted measures of remaining life years are however fraught with 
problems arising from the health and disability surveys themselves and other difficulties 
concerning their interpretation. 
5. Morbidity 
5.1 Introduction 
As life expectancy has increased substantially over the decades, there are increasing 
interests in measuring life expectancy that consider the health status of the population. 
A crucial question is that as we live longer, in what state of health do we live? 
Measuring health status of a population and comparing it with other populations has 
intrinsic interest as health is one of the most important factors that determines human 
well-being. Moreover, health has important implications in broad areas of economics, 
from productivity and labour supply to health care costs and the sustainability of public 
health care system. In this project, we attempt to measure and compare health status and 
health expectancies in European countries using survey data. 
5.2 Data 
One of the main data sources of self-assessed health status in Europe is European 
Community Household Panel survey (ECHP), which started in 1994 across 12 
European countries. Sampling and survey questions are carefully prepared to insure 
maximum comparability across countries. A further advantage of the ECHP is that 
surveyed countries share more or less similar culture and development levels as well as 
geographical proximity. One of the questions included in the survey regarding health 
status is “How is your health in general?” with possible responses, “very good”, “good”, 
“fair”, “bad” and “very bad”. Another question addresses chronic illness or disability, 
“Are you hampered in your daily activities by any chronic physical or mental health 28 | AHN, GÈNOVA, HERCE AND PEREIRA 
problem?” with possible responses, “Yes, severely”, “Yes, to some extent”, and “No”. 
We analyze the responses to these two questions to compare health status and health-
adjusted life expectancy across European countries. 
We examine only the first wave (1994) of the survey to avoid the problems of attrition.
4 
First, it is useful to check the internal consistency of self-assessed health status by 
examining the correlation between the two indices of health status that we will analyse. 
We expect a strong correlation between general health status and disability status: those 
who suffer from disability are likely to report worse health status. Indeed, as we can see 
in the table below, there exists a strong correlation between the two variables. The 
proportion that suffers some degree of disability increases substantially as the declared 
health status worsens: the disability proportion decreases from 92% to 83%, 41%, 8% 
and to 3% as the declared health status moves from ‘very bad’ to ‘bad’, ‘fair’, ‘good’, 
and to ‘very good’. When we examine each country, we find the same pattern without 
exception. This result is comforting as it provides some evidence for internal 
consistency at least at individual level. 
Table 6. Proportion with disability and annual medical consultation for 
each health status – ECHP 1994 
  General health status 
  Very Bad  Bad  Fair  Good  Very Good  Total 
% with 
disability 
 
91.79 83.43 40.66 8.35
 
2.59 22.23
    
Number of 
annual medical 
consultations 
 
8.54 7.55 5.28 3.14
 
2.34 3.91
    
Numbers 
observed 
3166 9716 29,423 52,250 32,181  126,736
 
Another check of internal consistency is performed by examining the correlation 
between health status and the use of health care services. Medical consultation 
frequencies increase significantly as individuals’ health status worsens. 
Another data source on health that we have available is national health survey carried 
out in various countries more or less regularly. Some advantages of the data from 
national health surveys are that sometimes the sample size is large to provide precision 
in health estimates of the population as well as permitting a higher level of 
disaggregation of the data, that in some countries it is carried out regularly over time to 
allow us to examine possible trend in health status of the population and that national 
health surveys usually include a wide variety of information concerning health status, 
                                                 
4 Attrition problem is likely to be serious in the analysis of health status as health could be a cause of 
attrition. Indeed, among the respondents aged 65 and more in the first wave of the ECHP, the proportion 
missing in the second wave were 14.3%, 11,6%, 13.8%, 16.3% and 24.4% respectively corresponding to 
the first-wave reported health status ‘very good’, ‘good’, ‘fair’, ‘bad’ and ‘very bad’. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 29 
self-assessed as well as diagnosis based, the use of health care facilities and health 
behaviour of the population. Table 7 presents the summary characteristics of the survey 
data available to us from various EU countries. 
Table 7. National health surveys 
Country  Year  Survey Title  Sample Size 
Spain 1987  Health  Survey  40,000 
 1993  =  26,000 
 1995  =  8400 
 1997  =  8400 
 1999  Disability  Survey  70,000 
Italy  1990-91  Health Conditions and Use of Health Services  67,000 
 1994  =  62,000 
 1999-2000  =  140,000 
Denmark 1987  Health  Survey  4700 
 1994  =  4700 
 2000  =  17,000 
Sweden 1990  Health  Survey   
 1995  =   
 2000  =   
Belgium 1997  Health  Survey  10,000+ 
 2001  =   
France  1999  Living Condition Survey   
Germany 1998  Health  Survey  7100 
 
5.3  General health status from ECHP 
The general health status question is based entirely on respondents’ own perception. 
The question asked is not concrete in terms of reference time period or in the 
description of each category of health status, therefore leaving a large room for 
interpretation variability by interviewees. Second, the possible responses are ordered 
qualitatively. Comparing the responses between groups of people is not straightforward. 
We begin with simple ‘averages’ of the responses after assigning a cardinal value for 
each response (‘very bad’=0, ‘bad’=1 and ‘very good’=4). The simple average provides 
a health index (the bigger the average, the better health), which is comparable across the 
populations if we are willing to assume the linearity across responses. The ‘average’ 
health status by five years age interval for 11 European countries is presented in Figure 
20. Luxembourg is excluded for its small sample size (Appendix A presents sample size 
for each country by five year age intervals.) 
The first impression we receive from the figure is that self-assessed health status 
becomes worse with age by a similar gradient across countries. More importantly, there 
are large differences in health status for given ages among the countries. For most age 
groups, Denmark and Ireland report best health status while Portugal, Italy and Spain 
report worst health status. 30 | AHN, GÈNOVA, HERCE AND PEREIRA 
 
Figure 20. Average health status ECHP 94 
Average Health Status: ECHP 94
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Peculiarly, Greece report best health among the young (less than 40) population but 
relatively worse health among the elderly (over 70) population. The differences among 
the countries is surprisingly large and the ranking is not completely convincing as 
judged by other health measures, such as life expectancy.
5 
Given that the comparison of ‘average’ health status analysed above is valid only in the 
case that the response categories can be assigned with linearly aligned values, the index 
loses substantive meaning in general. For the comparisons that suffer less from this 
arbitrary assignment of values, we compare the proportions who report good or very 
good health status as well as the proportions with bad or very bad health status. 
In the case of good or very good health, the proportion varies substantially between 
countries even among the young population and the difference widens with age. The 
cross-country differences are too large to accept as genuine differences. For example, 
the proportion in good health among the population aged 65-69 is less than 20% in 
Portugal while it is close to 60% in Ireland and Denmark.  
In the case of bad or very bad health, the differences across countries are even larger 
among the middle and old age population. For example, Ireland and The Netherlands 
have the proportion in bad or very bad health at lower than 10% among the population 
aged 65-69, while the corresponding proportion is higher than 30% in Portugal, Spain 
and Italy. 
                                                 
5 According to WHO (2000), life expectancy at birth is longest in France, Italy and Spain and shortest in 
Ireland, Portugal and Denmark with the differences of about 2.5 years between the two groups. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 31 
Figure 21. Proportion in good or very good health: ECHP 94 
Proportion in good or very good health:
ECHP 94
0,0
0,2
0,4
0,6
0,8
1,0
1 5-1 9 20-
24
25-
29
30-
34
35-
39
40-
44
45-
49
50-
54
55-
59
60-
64
65-
69
70-
74
75-
79
80-
84
85+
Germany
Denmark
Netherlands
Belgium
France
UK
Ireland
Italy
Greece
Spain
Portugal
 
 
Figure 22. Proportion in bad or very bad health ECHP 94 
Proportion in bad or very bad health: ECHP 94
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5.4  Disability status from ECHP 
The second question we analyse is disability status. In principle, we think that disability 
status would suffer less from the cultural or social environment bias, as the question is 
more concrete and less subjective. Given that the response categories are “none”, “to 
some extent” and “severely”, we consider the proportion with severe or moderate 
disability as well as that with only severe disability. 
The age profile of disability is as expected: older people suffer more often from 
disability. Cross-country differences are somewhat smaller than in the case of general 
health status. Nevertheless, the differences between countries are again substantial 
enough to lead us to be reluctant in accepting them as genuine differences across 
countries. For example, the proportion with some disability among the population aged 
16-24 is less than 5% in Spain and Greece while it is higher than 12% in The 
Netherlands. Among the population aged 55-59, as another example, the disability rate 
is less than 25% in Ireland and Greece while it is almost 40% in Germany and Portugal. 
If we examine the proportion with severe disability, the cross-country differences are 
proportionally larger, especially among the elderly population. Here, France stands out 
for its high prevalence of severe disability. For example, at ages 65 to 69, the severe 32 | AHN, GÈNOVA, HERCE AND PEREIRA 
disability rate is 22% in France while that in UK, Ireland and Spain is only 10%. 
Moreover, the country ranking of disability rate is widely different from that of general 
health status. A part of cross-country differences at old ages may be because of the 
differences in the proportion of institutionalised population, which is not included in the 
ECHP. 
 
Figure 23. Proportion with a disability: ECHP 94 
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Figure 24. Proportion with a severe disability: ECHP 94 
Proportion with severe disability: ECHP 94
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One potential factor that may contribute to cross-country differences in the perception 
of health status is the time (month) of year when the survey is carried out. Indeed, there 
were considerable variations between countries in the month of year when the surveys 
are carried out. It is possible that people enjoy different health status according to the 
season owing to seasonal variation of physical exercise. Mental health and mood may BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 33 
also vary according to the season. To explore this possibility, we estimated individual 
health status (ordered logit regression for health status and logit regression for disability 
status) including month and country dummies. The results indicate that month dummies 
are in general not significant and therefore not a factor that can explain the observed 
cross-country differences in self-assessed health status.  
In summary, self-assessed general health status and disability status vary widely across 
European countries. The differences are so large and often the country rankings change 
across different measures or do not coincide with other health measures (such as life 
expectancy) that we have to be careful in the interpretation of the cross-country 
differences. 
5.5  Cross-country comparisons using national health surveys 
Given the low reliability of the ECHP data in comparing health status across countries, 
we ask whether we can we use national health surveys of different countries to compare 
health status across countries. Cross-country comparisons of health status using national 
health surveys are in general less reliable than those using the ECHP owing to the 
differences in sample design across country.  
One advantage, however, is that in many countries the sample size of national health 
survey is much larger than that of ECHP, thus providing greater statistical precision in 
their estimates. In this section, we compare health status of Spain and Italy using the 
national health surveys from the two countries. The benefit of using these two countries 
is that they share similar language, culture and geo-demographic situation. For example, 
the life expectancy in 2001 according to WHO (2002) was 79.3 in Italy and 78.9 in 
Spain. 
We compare health status between Spain and Italy using two large sample surveys 
during the similar time period. For Spain, we use 1999 Disability Survey where the 
sample size is 70,000, while for Italy we use 1999-2000 Health Conditions and Use of 
Health Service Survey, which includes 140,000 individuals. The survey question 
regarding general health status is the same: “How is your health in general?” The 
possible responses are exactly same except for the middle category, which is “regular” 
in the Spanish survey and “discretamente” in the Italian survey. 
The proportion in good health is in general higher in Spain than in Italy. The difference 
becomes larger with age. The differences are substantial even among young population. 
For example, at ages 20-29 the proportion in good health is higher in Spain by almost 
10 percentage points than in Italy, and, at ages over 40, the difference is almost 20 
percentage points reaching more than 25 percentage points at ages 80 or more. 
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Figure 25. Proportion in good health: Italy vs. Spain 
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Figure 26. Proportion in bad health: Italy vs. Spain 
Proportion in Bad Health: Italy vs Spain
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With respect to the proportion in bad health the difference between the two countries is 
much smaller especially among the non-elderly population. In fact, the proportion is 
almost the same between the two countries at all ages up to 64. At ages over 64, the 
differences are again substantial with an increasing gap with age between the two 
countries. This result suggests that, even using large surveys from two countries who 
share similar cultural and demographic situation, the health status outcomes exhibit 
substantial differences hard to explain. 
5.6  Health trends according to ECHP (1994-2000) 
Given that we have now seven waves of the ECHP survey, we may attempt to examine 
the trend in self-assessed health status in Europe during the period between 1994 and 
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To obtain comparable estimates across time, we used 11 countries who participated 
from the first wave of the survey (again Luxembourg is excluded for its small sample 
size). To obtain the average health status we applied population weights (by country and 
age group) in 1995 for all the waves of the survey. The main advantage of applying the 
fixed population weights for different years is that the obtained averages are not 
affected by the changes in the population composition over the examined period. 
Therefore, the changes in average health status are exclusively owing to the changes in 
health status of the population. 
At the outset we must take into account that the data suffers from attrition bias whose 
magnitude is impossible to know. Furthermore, we should not expect any substantial 
changes in health status over such a short time period. Hence, any jumps in the average 
health status should be taken with caution. Rather, we expect a smooth and low-gradient 
(if any) evolution over time. 
We present evolutions in four types of self-perceived health status: in good (or very 
good) health, in bad (or very bad) health, with moderate or severe disability, and with 
severe disability. We present separately by gender and by 5 age groups, 16-24, 25-54, 
55-64, 65-74 and 75+.  
There were two irregularities to be resolved in the data. First, German Socio-Economic 
Panel survey, which is the data source for Germany did not include information on 
disability for 1994. Instead of excluding Germany, we opted to use the same disability 
rates as in 1995 for 1994. Second, in the UK the response categories for the general 
health status differed in 1999 from other years ‘excellent’, ‘very good’, ‘good’, ‘fair’ 
and ‘poor’ in 1999 compared to ‘excellent’, ‘good’, ‘fair’, ‘poor’, ‘very poor’ in all 
other years). To correct for this inconsistency we opted to use the average of 1998 and 
2000 for 1999. 
As we expected, average health status stays almost at the same level over the period. 
This is especially true for the proportions in good health. On the other hand, we observe 
a slight decrease in the proportion in bad health among the population older than 54 
years. The maximal change is observed for the age group 55-64 with a drop of 3 
percentage points over the six-year period. For the younger age groups (54 and younger) 
we observe almost no change. This can be seen in Figures 27a to 27d below.  36 | AHN, GÈNOVA, HERCE AND PEREIRA 
Figure 27. Health trends according to ECHP 
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With respect to disability rates, we observe, in Figures 28a and 28b, a significant drop 
for those over 54 years old between 1994 and 1995 and a stable pattern afterwards for 
all age groups, with few exceptions. That rather large improvement in only one year and 
almost no change thereafter lead us suspect its veracity. Severe disability rates show 
some increase at ages above 64 for both men and women 1996 and 1998, as shown in 
Figures 28b and 28c, and, again, a stable pattern for the rest of ages or years (or both). 
Our tentative conclusion is that there has been almost no change or if at all a slight 
improvement for those aged 55 and more in health and disability status over the 
observed period. This seems reasonable if we consider the short time period examined. 
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Figure 28. Health trends according to ECHP 
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5.7  Health trends from national health surveys 
For the purpose of assessing health trend, the ECHP surveys are not entirely appropriate 
since they cover only a short time period (1994-2000) and they suffer from attrition bias 
as it is probable that attrition probability is intrinsically related to health status. Instead, 
to assess possible trend we use the data from national health surveys for the countries 
where the surveys are available for different years. 
Given the wide differences in terms of survey design and definitions of health status 
between the surveys of different countries, we restrain ourselves from doing cross-
country comparisons of health trend. Rather, we limit ourselves at comparing the health 
surveys of different years within the same country. 
Spain 
Morbidity data in Spain are obtained from the national health survey (NHS) and 
disability survey (DS). Currently, we have available four cross-section data from NHS 
carried out in 1987, 1993, 1995 and 1997 and one cross-section data from DS carried 
out in 1999. The NHS is carried out mainly to assess health status, personal behaviours 
or lifestyles and health care service utilisation of the population, while the DS includes 
an extensive list of disability status. Both include a question regarding self perceived 
general health status where response categories are ‘very good’, ‘good’, ‘regular’, ‘bad’ 
and ‘very bad’. The sample sizes of the four NHS surveys are about 40,000 in 1987, 38 | AHN, GÈNOVA, HERCE AND PEREIRA 
26,000 in 1993, and 8400 in 1995 and 1997 each, and the sample size of the 1999 DS is 
close to 70,000 individuals. In Figure 29 we compare the proportion who report bad or 
very bad health by five-year age intervals. 
Figure 29. Proportion in bad health: Spain 1987-99 
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Between 1987 and 1993, there was a substantial drop in the proportion who reported 
bad health at ages over 50, while at ages below 50 there was no difference. Between 
1993 and 1995-7, we observe a substantial increase in the proportion of bad health, 
converging, in consequence, at the 1987 level. Between the period 1995-7 and 1999, 
there has been a substantial drop in the bad health proportion for all age groups. A part 
of the differences between 1999 and other years is that the reference period in the 1999 
survey was “in general” while it was “during the last 12 months” in other years. What 
do these differences by year tell us about trend? It is hard to say anything except that we 
should be very careful in interpreting the differences as trend. 
Another source of information on health status that we have available in the National 
Health Survey is the prevalence of chronic diseases. In principle, we think that chronic 
disease status would suffer less from the cultural or social norm bias, as the questions 
are more concrete and less subjective than the questions regarding general health status. 
However, we have to be aware that the prevalence rate of any chronic disease is 
conditioned by the medical consultation by individuals. A potential bias exists owing to 
the differential frequencies of medical examination over time or between populations. 
This problem is similar to the perception bias in the case of self-assessed health status. 
That is, the population who aspire better health would check their health more 
frequently with doctors, and therefore more diseases are likely to be detected. We 
examine the prevalence rate of High Blood Pressure as a representative example of 
chronic diseases (Figure 30). 
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Figure 30. Proportion with high blood pressure in Spain 
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Over time we observe an increasing prevalence rate of high brood pressure, especially 
among the elderly population. It should be noted, however, that this inter-temporal 
increase might be due to examination frequency bias as discussed above. Further studies 
are needed. A similar increasing trend of prevalence is observed for other chronic 
diseases such as Cholesterol, Diabetes and Heart problems. 
Italy 
Morbidity data from Italy is obtained from the National Survey of Health Conditions 
and Use of Health Services carried out by National Statistics Institute. We have three 
cross-section surveys carried out in 1990-91, 1994 and 1999-2000. One main advantage 
of the Italian health surveys is that the sample sizes are relatively large: about 67,000 
persons for the 1990-91 survey, 62,000 for the 1994 survey and 140,000 for the 1999-
2000 survey. We examine the trend using the general health status question: “How is 
your health in general?”. Results are shown in Figure 31. 
 
Figure 31. Proportion in bad health: Italy 1990-2000 
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According to Italian data, we observe worsening health status during the first half of 
1990s and improving health status during the second half of 1990s. The early worsening 
and the later improvement were of a similar magnitude to be offset almost exactly. 
Should we interpret these differences between years as genuine worsening and genuine 
improvement of population health in Italy? We think not. Further studies are needed. 
Denmark 
The sample size of Danish data is about 4700 for 1987 and 1994 each and about 17,000 
for 2000. Figure 32 shows the patterns for those three years. 
Figure 32. Proportion in bad health: Denmark 1987-2000 
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First, we can observe a higher volatility in the first two surveys due to their small 
sample size and a much smother age profile for 2000 most probably due to its large 
sample size.  
Over time, we observe a substantial health improvement between 1987 and 1994 at all 
ages over 60. Between 1994 and 2000 there is no clear trend. If we interpret the results 
literally, health status of Danish elderly population has improved during the first period 
(1987-1994) but has not improved during the second period (1994-2000). To ascertain 
or reject this interpretation we need further evidence. 
Sweden 
For Sweden we have available three different years (1990, 1995 and 2000) of health 
status data. The proportion in bad or very bad health is calculated separately for men 
and women and shown in Figures 33a and 33b. 
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Figure 33a. Proportion in bad health: Swedish men 1990-2000 
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Figure 33b. Proportion in bad health: Swedish women 1990-2000 
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0,00
0,05
0,10
0,15
0,20
0,25
  18-19   20-24      25-29      30-34      35-39      40-44      45-49      50-54      55-59      60-64      65-69      70-74      75-79      80-84   
1 990 1 995 2000
 
 
First, we can see highly volatile age profiles in all years probably due to small sample 
size. The comparison over time is difficult owing to high volatility; at some ages there is 
improvement but for other ages worsening and the trend varies between the period 90-
95 and 95-2000 depending on ages. We think it is extremely unreliable to interpret any 
trend using the Swedish data. 
5.8  Health and education in the EU 
Many studies have found a positive association between health and socioeconomic 
status (income, wealth, education and occupation level and employment status). Yet the 
direction of causation between them is difficult to establish, and is most likely that it 
runs both ways (see Bound, 1991; Dwyer and Mitchell, 1999 and the survey by Smith, 
1999). For example, those with better health are likely to be more productive and enjoy 
therefore greater earning potentials. On the other hand, greater wealth allows easier 
access to and better quality of health care therefore providing better health outcome. It 
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same direction, thus leading to the observed positive relation between the two. For 
example, those who are far sighted are likely to take more care of their health and 
therefore more productive and also save more, therefore leading to the observed positive 
association.  
Education level suffers less from endogeneity problems than other socioeconomic 
variables since most people complete their schooling relatively early (before age 25) 
when their health status is in most cases good enough not to interfere with their 
schooling. For example, as we could observe earlier, the proportion with bad or very 
bad health among those aged less than 35 is less than 5% in all the ECHP countries. 
Many studies have shown education as the single most important socioeconomic 
characteristic in determining various measures of health (see for example, Elo and 
Preston, 1996, in mortality and Freedman and Martin, 1999, in function limitations). 
Effect of education on general health status 
We first examine the effect of education on general health status. In Table 8 we present 
regression results of health status for the 11 European countries in ECHP. Three 
schooling levels are distinguished, low (omitted category), medium and high. 
 
Table 8. Effect of education level (relative to low education level) on health status (ordered 
logit coefficients in parenthesis are not significant at 5% level) 
Ages 25-44  Ages 45-64  Ages 65+   
Medium High  Medium  High  Medium  High 
Germany 0.176  0.508 0.292 0.757  0.385 0.421 
Denmark 0.551  0.903 0.769  0.988  0.258 0.553 
Netherlands 0.299  0.708  0.402  0.669  0.391  0.638 
Belgium 0.269  0.644 0.371  0.600  (0.363)  0.618 
France 0.304  0.405  0.355  0.613  0.322  0.588 
UK 0.322  0.778  0.473  0.869  0.449  0.754 
Ireland 0.675  0.904  0.485  0.991  0.759  1.145 
Italy 0.342  0.672  0.444  0.610  0.548  1.008 
Greece 0.172  0.300  0.597  0.832  0.433  1.062 
Spain 0.365  0.599  0.824  1.145  1.038  0.817 
Portugal 0.701  1.055  1.209  0.969  1.282  0.998 
 
The results are encouraging. Among the 66 estimated coefficients, only one (medium 
education level for ages 65+ in Belgium) is not significant at 5% level. We can see 
persistently substantial effects of education on self-assessed health status across 
countries and for all age groups, suggesting that genuine beneficial effects of education 
exists in health. This hypothesis is supported by the fact that even when we include 
other socioeconomic variables, such as employment status and household income, the 
education coefficients maintain almost entirely their magnitude and statistical 
significance. 
Effect of education on disability 
Education again stands out as an important factor in determining the probability of 
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substantially the probability of suffering disability. This difference by education level is 
greater among younger people than those over 64 years. Among those 65 or older, only 
those with high education level enjoy significantly lower rates of disability and this 
effect of high education is greater among the southern European countries than other 
countries (Table 9). 
Table 9. Effect of education level (omitted: low) on disability status (logit coefficients in 
parenthesis are not significant at 5% level) 
25-44 45-64  65+   
Medium High  Medium  High  Medium  High 
Germany (0.045)  -0.366  (-0.083)  -0.447  (-0.101)  (-0.142) 
Denmark -0.848  -1.014 -0.675 -0.896  (-0.150)  (-0.281) 
Netherlands -0.281 -0.640  -0.341  -0.693  (-0.102) (-0.259) 
Belgium -0.272  -0.952  -0.379  -0.386  (-0.193)  -0.386 
France -0.374  -0.900  -0.324  -1.169  -0.250  -0.512 
UK -0.223  -0.607  -0.279  -0.542  (-0.145)  -0.345 
Ireland -0.824  -1.082  -0.632  -1.198  (-0.154)  -0.933 
Italy -0.390  -0.992  -0.629  -0.835  -0.285  -0.870 
Greece -0.453  -0.518  -0.586  -0.996  (-0.187)  -1.028 
Spain -0.676  -1.222  -0.791  -1.441  -0.800  -0.677 
Portugal -0.671  -0.730  -0.863  -0.524  -0.938  -0.498 
 
Educational composition to explain cross-country health status differences 
Given the persistent effect of education level on individual health status for all countries 
analysed, we may ask whether it is the difference in educational composition that 
explain cross-country differences in health status. Indeed, education level shows 
substantial differences among the countries across the age groups. For example, the 
proportion of people with a high level of education is close to 40% in Belgium and 
Denmark while it is less than or close to 10% in Portugal and Italy among those aged 25 
to 44. Similar differences exist for other age groups as seen in Table 10. 
 
Table 10. Educational composition : ECHP 94 
Ages 25-44  Ages 45-64  Ages 65+   
% medium  % high  % medium  % high  % medium  % high 
Belgium  34.98 39.14 27.49 26.65 22.57 13.42 
Denmark 40.88 39.11 35.06 31.21 24.09 14.40 
France  46.21 24.30 31.50 15.67 15.27  7.00 
Germany 55.31 23.49 46.55 21.52 38.21 14.30 
Greece  31.40 28.12 15.24 11.21  9.03  4.16 
Ireland  42.40 16.63 27.36 10.80 12.89  5.63 
Italy  42.63 10.12 20.78  6.34  13.17  3.80 
Netherlands  63.10 21.39 56.58 18.07 43.61  9.91 
Portugal 12.69  6.62 3.17 3.43 1.41 1.17 
Spain  20.20  24.81  6.92 9.18 3.88 3.94 
UK  38.61 26.11 27.85 19.98 18.49 10.72 
 44 | AHN, GÈNOVA, HERCE AND PEREIRA 
To contrast the hypothesis, we examine the health status by education level for three age 
groups as defined earlier as shown in the following Figure 34a to 34c. If the individuals 
in the same education category but in different countries show similar levels of health 
status, cross-country health status differences could be attributed to the compositional 
differences in education. 
 
Figure 34a. Average health status by education: ECHP 94 – ages 25-44 
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Figure 34b. Average health status by education: ECHP 94 – ages 45-64 
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The hypothesis can be rejected clearly. Education level affects significantly individual 
health status in all countries as shown in the positive slope. Nevertheless, education 
profiles of health status are parallel between countries for most countries. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 45 
Figure 34c. Average health status by education: ECHP 94 – ages 65+ 
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Cross-country health status variations at each level of education are much greater than 
the variations by education within each country. Therefore, the differences in health 
status between countries are attributed more to the country specific effects than to the 
educational composition. 
6. Health-adjusted  life  expectancies: Trends and projections 
6.1  Concept and illustration 
Health expectancies are summary measures of population health that estimate the mean 
time (in years) that a person can expect to live in a specific health state. Health 
expectancy is a generic term used for any life expectancy lived in a specific health state, 
which includes good health (i.e. disability-free) or poor health (i.e. disabled). 
Since the late 1980s, an international group called ‘REVES’ headed by J.-M’ Robine 
has developed and promoted the concepts and methodology for the calculation of these 
indicators, which are currently widely calculated and used by different countries for the 
evaluation of population health status (Mathers et al., 1993). In a wider perspective, the 
World Health Organisation has published in recent years different indicators of health 
expectancies (WHO, 2000, 2001 and 2002) for all member states. 
When using health expectancies, the years lived are not equally considered 
independently of the health state as it occurs when calculating life expectancy, but the 
distinction is made between years lived in perfect health and years lived with some type 
of health problem. Health expectancy indicators thus constitute an attractive instrument 
for the long term follow-up of population health tendencies. They can be easily 
interpreted as an extension of the life expectancy concept. 
Yet, for them to be really useful, these indicators must be comparable among 
populations and through time. This means, on one hand, using homogenous concepts 
and definitions of health and, on the other hand, using comparable tools to obtain the 
information about the population health status. Finally, several methods to calculate 
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is the need to define what is understood by health, in other words, under what criteria 
the health status of a population is established. For all these reasons, it is not a surprise 
that there are as many possible health expectancy measures as health concepts and 
methods to calculate them (Robine et al., 1999). 
Conceptual background 
The most frequently used method for calculating health expectancy measures is 
Sullivan’s method. It uses disability prevalence data or population health status data to 
distinguish between hypothetical years of life lived with or without disability for a 
fictitious cohort derived from a period mortality table. The main limitations of this 
methodology are: comparability between populations (can only be partially achieved 
using common standardised models of protocols and questionnaires); the lack of 
information about the transition or reversibility of different health states or disabilities; 
and that they offer stock information, that is, accumulated results of the consequences of 
incidence of diseases and injuries that did not necessarily occur at the same year in 
which the survey took place.  
The main advantages of Sullivan’s method lie in the simplicity of the calculations and 
the relative easiness to obtain required information: it only requires a mortality table and 
health state prevalence of the population, which can be obtained easily from health or 
disability surveys. In some cases, data can even be obtained from some census 
questionnaires. Table 11 shows health expectancy calculated using Sullivan’s method 
with Spanish data from the national health survey in 1997. 
 
Table 11. An illustrative example of health expectancy calculation 
Use of Sullivan method to calculate health expectancy in good  
health and bad health, Spain, 1997, both sexes. 
Life table  Years in  Life expectancy in 
Age 
l(x) nL(x) E(x) 
% persons in
Bad health  Bad 
health 
Good 
health 
Bad 
health 
Good 
health 
0-4 100,000  497,232  78.79  14.7%  73,093  424,139  23.8  55.0 
5-14 99,371 992,918  74.28  7.2%  71,490  921,428  23.2  51.0 
15-24 99,203  989,699  64.40  15.7%  155,383  834,316  22.6  41.8 
25-44 98,695 1,952,508 54.70  19.1%  372,929 1,579,579 21.1  33.6 
45.64 96,140 1,848,692 35.85  42.0%  776,451 1,072,242 17.8  18.1 
65-74 86,196  795,833  18.53  56.3%  448,054  347,779  10.8  7.7 
75 +  70,950  801,677  11.30  60.6%  485,816  315,861  6.8  4.5 
Sources: Spanish National Health Survey 1997. Ministry of Health. Population projections 1991-2050. 
INE. MNP (Vital Statistics). Mortalities by age. INE. 
 
The most common data on health states or disability prevalence come from health 
surveys (i.e. national health surveys, carried out in many countries) or disability surveys 
(based on the definitions and recommendations of International Classification of 
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Another source is the International Classification of Functioning, Disability and Health 
(ICF), which has just recently appeared. Some countries also have health-related 
questions included in their census questionnaire. There is more than one question 
included in these surveys that is potentially useful to calculate HE.  
Thus, from these sources one can calculate age-specific perceived health state 
prevalence (proportion of population by health status), age-specific disability prevalence 
(proportion of population with disability), age-specific handicap prevalence (proportion 
of population handicapped), and so on. These prevalence rates can also be disaggregated 
by severity. 
Some estimates from the WHO 
World Health Organisation has calculated health expectancies for all member countries 
in its World Health Report of recent years. Estimates for year 2000 (WHO, 2001) for 
the countries of European Union are presented in Table 12 and Figures 35 (at birth) and 
36 (at age 60). 
Table 12. Health-adjusted life expectancy 
  Loss of Healthy life (at birth) 
Country  At Birth  At 60 years 
  Years  as % of LE 
  Men Women Men Women   Men Women Men Women
France  68,5 72,9 16,6 19,4   6,7  10,2 8,9%  12,2% 
Italy  69,5 72,8 16,3 18,8   6,4  9,6 8,5%  11,6% 
Sweden  70,1 72,7 16,8 18,7   7,2  9,2 9,3%  11,3% 
Spain  68,7 72,5 15,8 18,3   6,6  9,8 8,8%  11,9% 
Austria  68,1 72,5 15,2 18,4   6,8  8,9 9,0%  10,9% 
Greece  69,7 72,3 16,0 17,6   5,7  8,5 7,6%  10,5% 
Luxembourg  67,6 72,0 14,9 18,4   6,3  8,7 8,5%  10,8% 
Germany  67,4 71,5 14,8 17,6   6,9  9,2 9,3%  11,4% 
Finland  66,1 71,5 14,8 17,9   7,6  9,5 10,3%  11,7% 
United  Kingdom  68,3 71,4 15,3 17,4   6,5  8,5 8,7%  10,6% 
The  Netherlands  68,2 71,2 15,2 17,8   7,3  9,7 9,6%  12,0% 
Belgium  67,7 71,0 15,3 18,0   6,9  9,9 9,2%  12,2% 
Ireland  67,8 70,9 14,3 16,9   6,3  8,8 8,5%  11,0% 
Denmark  68,9 70,1 15,7 16,5   5,3  8,4 7,2%  10,7% 
Portugal  63,9 68,6 13,6 16,0   7,8  10,7  10,9%  13,5% 
Source: World Health Organisation, The World Health Report 2001, Statistical Annex, Table 5, WHO, Geneva.
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Figure 35. Health-adjusted life expectancy at birth – EU countries, 2000 
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Figure 36. Health-adjusted life expectancy at age 60 – EU countries, 2000 
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Both at birth and at age 60 French women and Swedish men are on the top of the 
ranking while Portuguese men and women rank in the worst position. Differences 
between sexes are the highest in Finland and Luxembourg and the lowest Denmark. 
Health expectancies using ECHP 
There is one statistical source common for all EU countries. The European Community 
Household Panel (ECHP) is a survey (conducted yearly since 1994) based on a 
standardised questionnaire that involves annual interviewing of a representative panel of 
households and individuals in each country, covering a wide range of topics. Main 
questions regarding health and disability in ECPH are related to self perceived health 
and disability. Although the questionnaire (questions and scale of responses) is virtually 
the same in all countries, it became apparent from these surveys that standardised 
instruments did not solve the problems of comparability across countries. These 
problems relate much more fundamentally to unmeasured differences in expectations 
and norms for health. Mathers (2003) and Sadana et al (2002) also highlight this 
problem. 
After calculating disability-free life expectancies (DFLE) in the EU countries with the 
Sullivan method using data from the ECHP 1994 and life tables supplied by Eurostat, 
Robine et al. (2001) evaluate the advantages of this source, but also point to some 
problems such as different versions of questionnaire, different rate of response and the 
exclusion of institutionalised population in the sample. 
According to 1994 wave ECHP, Greece is the population with a highest level of DFLE 
at birth (measured in years of life without disability, both for men and women. The 
worst figures belong to Portugal. At ages 65, Italy (men) and Germany (women) have 
the worst situation, and France and Luxembourg the best one. As a proportion of total 
life expectancy, the ranking is not exactly the same (because the differences in LE are 
not always the same as of the DFLE), but quite similar: Portugal, Italy, Germany and 
The Netherlands in the group with low proportions, and Greece, Luxembourg, Ireland 
and Denmark in the group with high proportions. 
ECHP database also permits to calculate DFLE by level of severity. The years lived 
with disability are discomposed between ‘moderate disability’ and ‘severe disability’. 
For all countries except France, a higher proportion of disability belongs to ‘moderate 
disability’. For the elderly population, the proportion of severe disability tends to 
increase and often becomes a dominating proportion of disability years in the last open-
age interval (85+). 
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Figure 37. Life expectancy (...) women 
Life Expectancy at Birth Free of Disability, 
with Moderate Disability and with Severe Disability
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Figure 38. Life expectancy (...) men 
Life Expectancy at Birth Free of Disability, 
with Moderate Disability and with Severe Disability
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Figure 39. Life expectancy (…) women 
Life Expectancy at age 65 Free of Disability, 
with Moderate Disability and with Severe Disability
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Figure 40. Life expectancy (…) men 
Life Expectancy at age 65 Free of Disability, 
with Moderate Disability and with Severe Disability
European Union. Year 1994. Men
0 5 10 15 20 25
France
Greece
Spain
Italy
Belgium
The Netherlands
Germany
Luxembourg
United Kingdom
Portugal
Denmark
Ireland
Years of Life
DFLE
DLEm
DLEs
 
 52 | AHN, GÈNOVA, HERCE AND PEREIRA 
Table 13. Life expectancy at birth and at age 65 (…) both sexes 
 
Life Expectancy at birth and at age 65 Free of Disability,
with Moderate Disability and with Severe Disability
European Union. Year 1994. Both Sexes
At birth Women At birth Men
DFLE DLEm DLEs LE DFLE DLEm DLEs LE
France 64,6 8,2 9,1 81,9 Greece 63,0 7,5 4,7 75,2
Spain 63,5 12,0 5,9 81,4 Italy 60,4 9,5 4,6 74,6
Italy 61,1 13,0 6,9 81,0 The Netherlands 59,0 11,1 4,5 74,6
The Netherlands 58,9 15,3 6,2 80,3 Spain 61,8 8,2 4,2 74,2
Greece 65,0 9,5 5,7 80,2 United Kingdom 59,1 11,5 3,6 74,1
Belgium 61,4 12,9 5,8 80,1 France 60,1 6,7 6,9 73,8
Luxembourg 60,9 15,5 3,3 79,7 Belgium 60,3 9,0 4,1 73,4
Germany 60,0 14,1 5,5 79,6 Luxembourg 59,2 10,9 3,1 73,2
United Kingdom 60,8 13,8 4,7 79,3 Germany 56,7 11,5 5,0 73,1
Ireland 64,0 11,7 2,9 78,6 Ireland 61,2 9,2 2,6 73,0
Portugal 56,7 15,1 6,8 78,6 Denmark 60,7 8,9 3,1 72,7
Denmark 61,3 12,6 4,2 78,1 Portugal 55,0 11,0 5,6 71,6
Age 65 Women Age 65 Men
DFLE DLEm DLEs LE DFLE DLEm DLEs LE
France 10,3 4,4 5,9 20,6 France 8,9 3,0 4,3 16,2
Spain 9,1 6,4 4,3 19,8 Greece 8,7 4,4 3,1 16,1
Italy 7,7 6,7 5,0 19,4 Spain 9,0 4,7 2,3 16,0
Belgium 9,2 6,1 3,8 19,1 Italy 7,7 4,6 3,3 15,6
The Netherlands 8,6 6,5 4,0 19,1 Belgium 8,1 4,3 2,3 14,8
Luxembourg 10,4 6,6 1,7 18,7 The Netherlands 8,4 3,9 2,5 14,8
Germany 7,9 6,6 3,9 18,4 Germany 6,5 5,0 3,2 14,7
Greece 9,7 5,1 3,6 18,4 Luxembourg 9,5 3,8 1,3 14,6
United Kingdom 8,5 6,4 3,4 18,3 United Kingdom 7,6 4,8 2,2 14,6
Portugal 7,9 6,1 3,9 17,9 Portugal 7,1 4,3 3,0 14,4
Denmark 9,2 5,6 2,9 17,7 Denmark 8,9 3,6 1,9 14,3
Ireland 9,8 6,0 1,5 17,3 Ireland 8,2 4,1 1,5 13,8
Source: Eurostat. European Community Household Panel.  
 
6.2 Data 
Health data 
European Community Household Panel surveys provide health data from 1994 to 2000 
for 11 countries: Belgium, Denmark, Germany, Ireland, Greece, Spain, France, Italy, 
The Netherlands, Portugal and the United Kingdom. 
There are some problems in the use of this survey for cross-country comparison 
purposes and even to compare the results for a country in different years. These 
questions are extensively discussed in the previous section will not be commented upon 
here. With these problems in mind, we try to describe here the main tendencies found in 
the period 1994-1998. 
The health related items from the ECPH questionnaire are: 
a)  self-assessed health status: How is your health in general? (very 
good/good/fair/bad/very bad); 
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i)  only in 1994: “Are you hampered in your daily activities by any chronic, 
physical or mental health problem, illness or disability?” (Yes, severely/Yes, to 
some extent/No); 
ii)  from 1995 to 2000: Do you have any chronic, physical or mental health 
problem, illness or disability? (yes/no); and 
iii) from 1995 to 2000: “Are you hampered in your daily activities by this chronic, 
physical or mental health problem, illness or disability?” (Yes, severely/Yes, to 
some extent/No). 
Four types of health status have been estimated using these questions: 
a)  good health (= very good + good); 
b)  bad health (= bad + very bad); 
c)  disability (any level) (= Yes, severely +Yes, to some extent); 
d)  severe disability (= Yes, severely). 
Health and disability prevalence age groups range from 16 to 85+ years old by 5 year 
intervals. Prevalence for the first age group, 16-19, have been applied to the 15-19 
population group, in order to obtain an HE at age 15. No HE data at younger ages (0-14) 
have been estimated. 
We have also estimated trends in HE using national sources, when available. Countries 
with national data on self-assessed health for more than one year of observation are 
Belgium, Italy, Spain, Denmark and Sweden. 
Belgium. HE data have been directly taken from the Federal Planning Bureau 
calculations, which used data from the National Institute of Statistics – Institut Pasteur 
– national health surveys, 1997 and 2001. 
Italy. Prevalence data on self assessed health are taken from the Indagine multiscopo 
sulle famiglie, condizioni di salute e ricorso ai servizi sanitari produced by the National 
Statistical Office (ISTAT), for the years 1990-91, 1994 and 1999-2000. ISTAT also 
provides the life table series. We have used the 1998 LT (the last available year) to 
compute the HE for 1999-2000 health data. 
Spain. Prevalence data on self assessed health are taken from the national health survey 
(Ministry of Health), for the years 1987, 1993, 1995 and 1997. LT have been calculated 
using data on population and mortalities by age and sex for selected years provided by 
National Statistics Institute.  
Denmark. Prevalence data on self assessed health are taken for the years 1987, 1994 and 
2000. LT data have been calculated using data on population and mortalities by age and 
sex for selected years. 
Sweden. Prevalence data on self assessed health are taken from the ULF survey, carried 
out by the Statistical Central Bureau, for the years 1990, 1995 and 2000. We do not 
have published LT nor raw data (population and mortalities by age and sex) to calculate 
them for desired years, so we have used the Eurostat Swedish LT available at 
Newcronos database. 
 54 | AHN, GÈNOVA, HERCE AND PEREIRA 
Mortality data 
The Sullivan method has been used to calculate HE. Prevalence of health status (self-
assessed health, disability) has been combined with life tables (LT) information, namely 
survivors at exact ages –l(x)-, stationary population –L(x)- and life expectancy –e(x)-) 
for selected years. Mortality age groups range from 15 to 85+ years old. Health and 
disability prevalence age groups range from 16 to 85+ years old. Prevalence for the first 
age group, 16-19, have been applied to the 15-19 population group, in order to get a HE 
at age 15. No HE data at younger ages (0-14) have been estimated. 
For years 1994 to 1999 we have used Eurostat LT available at Newcronos database. 
This common source guarantees no methodological biases in the mortality base for 
computation of HE. Probabilities between exact ages –q(x)- and life expectancies –e(x)- 
are the only LT series provided by Newcronos. We have calculated the rest of series 
(survivors at exact ages –l(x)-, stationary population –L(x)-) needed to apply the 
Sullivan method for computation of HE. 
This mortality information, however, is not available for all countries for all years. This 
includes the year 1998 (only available for France and Spain), and 1996-99 for Italy. In 
order to fill this hole we have calculated LTs using the information on mortalities by sex 
and age, and population by sex and age provided by Eurostat’s Newcronos database. 
We have used the actuarial method of construction of LT (regular distribution of 
mortalities between exact ages, except the first age, to which we have applied a fixed 
ratio equal to 0.15–0.85. We were not able to know the precise methodology used by 
Eurostat to construct their LT. For this reason, our LT being a fine replication of these 
are not however an exact replica. Differences are nevertheless negligible and do not 
affect to the HE calculations. 
For the year 2000 (1999 and 2000 for Italy) we have used the LT projected by Eurostat 
and available at the Newcronos database. 
6.3  Trends in health expectancies 1994-2000 
Data in the ECHP allows us thus to compute the basic health expectancy indicators for 
EU countries. This is what we do in this section through four different indicators for 
men and women and at age 65, that is, LEGH or life expectancy in good health, LEBH 
or life expectancy in bad health, DFLE or disability-free life expectancy and SDFLE or 
severe disability-free life expectancy. As explained before when discussing health status 
for EU countries, comparisons among countries are not straightforward owing to several 
factors. On the other hand, for any given country, comparisons of results through time 
are equally flawed because of attrition, among other causes. 
Life expectancy in good health (LEGH). 
As shown in Figures 41 and 42, the level of LEGH is not the same between countries. 
We can organise them in groups, including: IRE, UK, NET, DEN and BEL (with 
highest values of LEGH), GRE, SPA and FRA and ITA, GER and POR that has the 
lowest LEGH. These groups remain the same both for males and females. 
Values of LEGH at 65 in 2000 range for females from 10.21 years in Ireland to 1.11 in 
Portugal, which is amazingly low, and from 8.89 in Ireland to 1.77 in Portugal for males BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 55 
in that same year. In relative term as a proportion of life expectancy at age 65 the above 
figures mean that aged Irish men will still expect to live a 63.1% of their remaining 
lifetime in good health, while Portuguese men will enjoy a mere 12.4% of their 
remaining life years in good health. For Irish or Portuguese women these percentages 
are 56.7% and 6.2% respectively. 
The expected years of life in good health have clearly increased during the period, for 
men, in Ireland, Greece, Spain and The Netherlands if we disregard the decrease 
observed in 1996. France and Portugal show an evident decrease of this indicator. The 
rest of the countries, Belgium, Denmark, Germany, Italy and the UK, show an erratic 
pattern with a no clear-cut trend in the 1994 to 2000 period. As for women, data allows 
to form the same country groups than for men when we look at the general level of 
LEGH. Concerning trends, however Belgium and Ireland show a clear increase of 
female LEGH with time. Spain, the UK, Germany and Denmark show some global 
improvement but with some oscillations. Portugal and France show a clear decrease 
through the period. The rest of the countries do not have a clear pattern. 
 
Figure 41. Life expectancy in good health at age 65 
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Figure 42. Life expectancy in good health at age 65 (as % of life expectancy) 
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Life expectancy in bad health (LEBH) 
Trends in LEBH are shown in Figures 43 and 44 below and are, in general, symmetric 
to the good health ones (as the former increases, the latter decreases). But there are 
some exceptions because of the fact that neither grouping contains the ‘fair’ grade of 
health that has a prevalence that differs among countries or changes across time (or 
both). 
Both the number of years lived in bad health and the percentages of these over total life 
expectancy at 65 are in general greater for females than for males. The range of values 
for different countries is extremely wide. LEBH for year 2000 for females of age 65 is 
10.17 in Portugal and 1.32 for Ireland. Concerning men, figures for that same year are 
6.39 and 0.98, respectively. Portugal and Ireland represent the opposite extremes of the 
distribution in the level of self-assessed health status according to the ECPH data. 
Nevertheless, these are the two countries with the lowest life expectancies in the EU, 
both for males and females. Correlations between LE and health status indicators thus 
are not easy to establish contrary to what one would guess at first glace. 
The highest LEBH for men is found in Portugal; an intermediate group includes Italy, 
Germany, Spain, Greece and France. Finally, the United Kingdom, Denmark, Belgium, 
the Netherlands and Ireland are the countries with the best relative position in LEBH. 
For the women groupings are similar to the just discussed, although not so clear-cut. 
Time trends for men concerning LEBH show that for Portugal, France and Denmark the 
number of years lived in bad health is increasing. For Ireland, Spain, Greece and Italy, 
however, there is a clear, strong decrease. The rest of countries have an erratic or stable 
behaviour. On the other hand, LEBH time trends for women show an increase in 
Portugal and the United Kingdom, a clear decrease in Spain, Greece and Ireland, a 
certain decrease in Belgium, Italy and Denmark and an erratic or stable behaviour in 
Germany, the Netherlands and France. 
Figure 43. Life expectancy in bad health at age 65  
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Source: ECHP and own computations. 
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Figure 44. Life expectancy in bad health at age 65 (as % of life expectancy) 
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Disability-free life expectancy (DFLE). 
Globally speaking, distances among countries in what concerns DFLE are smaller than 
for LEGH or LEBH, with the exception of Germany, clearly below the rest for all years. 
The UK does not appear in this series. This can be seen in Figures 45 and 46 below. 
Most of countries display an increase in DFLE. But some problems seem to exist with 
data for 1994 compared with the rest of years in the period analysed. Both for males and 
females, values in 1994 are quite smaller than for the rest of years. Only France has the 
opposite situation: 1994 data are higher than for the other years. We must remember 
here there was a change in the questionnaire just for this item in 1995 in relation to 
1994. 
For the five years of the period, DFLE tends to increase in most of countries, unless 
France. But if we don’t take in account this first year 1994, trends in DFLE become 
more complex. Both for males and females, Spain, Greece, Ireland and Italy show an 
increase of the years lived without disability. Denmark, Belgium, Portugal and France 
tend to decrease the DFLE. 
Figure 45. Life expectancy free of disability at age 65 
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Figure 46. Life expectancy free of disability at age 65 (as % of life expectancy) 
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Severe disability-free life expectancy (SDFLE). 
Figures 47 and 48 show how SDFLE has in general more erratic trends than DFLE. 
According to ECPH, Spain is the country with the highest number of years free of 
severe disability after age 65 during the whole period (1994-00) and both for males and 
females. On the other hand, the UK, Portugal and Germany have the least years free of 
severe disability at age 65 of all countries. Both for males and females, SDFLE in 
Ireland, Spain and Italy tend to increase while for France, Belgium, Portugal and the 
UK the number of years lived without severe disability tend to decrease. In Germany, 
the Netherlands and Denmark this indicators does not show a clear pattern. 
 
Figure 47. Life expectancy free of severe disability at age 65 
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Figure 48. Life expectancy free of severe disability at age 65 (as % of life expectancy) 
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Summing up 
Globally speaking, we find a great divergence of trends between countries and few clear 
trends. We may distinguish, however, certain groups of countries. Spain, Ireland, 
Greece and Italy seem to improve their health (increase of DFLE and LEGH, decrease 
of LEBH), while Portugal and France show a deteriorating trend in their health. We do 
not know whether this is a genuine picture of the health status of the EU population, or 
the results of other factors such as culture, social norm and measurement errors 
imbedded in health data. We think it is difficult under this circumstance to establish any 
coherent set of hypothesis for projections of health status based on past trends. 
To be sure, when considering the considerable gains in life expectancy that European 
and other developed nations have witnessed in the last one hundred years one has to 
reckon with formidable advances in public health policies and health care systems to be 
able to explain that change. Although certain maladies have receded, new forms of 
morbidity are increasingly hitting people reaching high ages. Unless we have longer and 
more precise longitudinal evidence on the many aspects of morbidity we will not be 
able to discern how such health transitions are actually occurring. The ECHP is a very 
valuable tool for this purpose, but its evidence concerning morbidity is so far just too 
short on longitudinal terms. Moreover, the ECHP has not been specifically targeted for 
measuring morbidity the same way as national health surveys (NHS) have. Let us now 
revise the evidence we have been able to gather based on NHS data. 
Trends in health expectancy according to data from national sources 
We dispose of national sources of information on health for more than one year only for 
five countries: Belgium, Denmark, Sweden, Italy and Spain. For these countries we 
examine time trends in health expectancy. 
The period covered varies from 4 years for Belgium (1997-2001) to 13 years for 
Denmark (1987-2000). The other three countries have a period of ten years: Spain for 
1987-1997, Sweden for 1990-2000 and Italy for1990-2000. Since it is not suitable to 
compare the results across countries, we summarise the main trends found for each 
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Sweden. LEGH tend to increase, both for males and females and both at 15 and at 65 
years of age. At age 65, the LEGH decreased during the first half of 1990s but increased 
during the second half of the same decade. Years lived in bad health tend to remain 
stable or increase slightly over time. 
Denmark. A remarkable improvement of health status over time is observed. Years 
lived in good health have increased even faster than the life expectancy. This is 
observed at both young (15) and old (65) ages. LE in bad health has decreased in both 
absolute numbers of years and as a proportion of the life expectancy. 
Italy. Trends in Italy appear irregular. For the first observed year (1990), LEGH is just a 
little higher than LEBH, but in second (1994) and third (2000) observed years health 
becomes worse. Changes are too large relative to the short time period and thus difficult 
to attribute them as a genuine change. 
Belgium. We have only two time references for Belgium, and they are too close (only 4 
years) one another to even attempt to examine trends. Reading the results literally, we 
can see LEGH has increased in absolute number of year, but decreased in proportion to 
life expectancy at age 65 for men. 
Spain. Health Expectancies in Spain show a light improvement over time except for the 
period 1993-1995. 
In summary, our examination of the data from the national health surveys leads us to 
conclude that it is impossible to establish any trend of health status and health 
expectancies using these data. 
6.4  Relationship between life expectancy and health expectancy 
In this section we examine the relationship between life expectancy and health 
expectancy for the years 1994-1998 for which we have data for health status (ECHP). 
The purpose of this exercise is to see if there is any consistent and reasonable 
relationship between the two that can be used for the projection of the health 
expectancy. Life expectancy data for the years 1994 to 1998 are obtained from Eurostat 
Newcronos database. Health expectancies for each year are computed combining the 
life expectancy and health prevalence data from ECHP by Sullivan method. We 
computed the HE at age 15. We compare life expectancy with several measures of 
health expectancy, in good health, disability-free and severe disability-free. For each 
comparison, we have 55 data points (11 countries for five years, 1994-1998). 
Life expectancy in good health vs. LE 
As shown in Figure 49, there is a big dispersion of the observations and if at all a 
negative correlation between LE and LEGH is negative although the former explains an 
insignificant variation of the latter as measured by the squared R. If we interpret literally 
the regression results, a one year increase in LE at age 65 would decrease life 
expectancy in good health by 0.65 years for men and by 0.54 for women. Of course, this 
pooling of data needs to be controlled in many ways in order to yield interpretable 
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Figure 49. Correlation between LE and LEGD at age 65 in the EU 1994-2000 
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Life expectancy in bad health vs. life expectancy 
Life expectancy in bad health has a positive correlation with LE as shown in Figure 50 
below. Again, the variation on the former that is explained by the latter is extremely low 
and thus this crude evidence is not to be taken too literally. When so interpreted it 
would mean that for every year gained to LE at 65 men would spend 0.65 years in bad 
health while women would spend 0.35 years. 
Figure 50. Correlation between LE and LEBD at age  65 in the EU 1994-2000 
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Source: ECHP and own computations 
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Disability-free life expectancy vs. life expectancy 
As shown in Figure 51, there is again a big dispersion of the observations concerning 
this correlation as well as an almost null explanatory power of the independent variable 
LE. Both men and women would live a positive fraction of LE gains free of disability 
with that of men being larger than for women. 
 
Figure 51. Correlation between LE and DFLE at age 65 in the EU 1994-2000 
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Source: ECHP and own computations. 
 
Severe disability-free life expectancy vs. life expectancy 
As shown in Figure 52, finally, both men and women have a positive correlation 
between LE and life expectancy lived free of severe disability. In this case, clearly, the 
variation of SDFLE is better explained by LE than for the previously analysed 
indicators, although in a limited way. The interpretation of the slopes shown and the 
coefficients is similar to the cases above, that is an extra year in LE at 65 would mean 
0.53 years lived free of severe disability for men and 0.4 years for women. BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 63 
Figure 52. Correlation between LE and SDFLE at age 65 in the EU 1994-2000 
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6.5  Conventional scenarios for health-adjusted life expectancy 
Given the absence of sensible patterns among health and life expectancies out of the 
ECHP data, a simple but consistent procedure is used to create health expectancy 
scenarios for EU countries. We define three indicators of HE: in good health, disability-
free and severe disability-free. Computations are made at ages 15 and 65. 
With respect to trend in health status in the future, we explore two variants. The first 
one assumes that the proportion of HE over LE stays constant at the average level of the 
period 1994-1998. This we call this ‘constant relative morbidity’ hypothesis. The 
second one assumes that the years in an unhealthy state (not in good health or with 
disability) remain constant at the average level of the period 1994-1998
6 or ‘constant 
absolute morbidity’ hypothesis. The first assumption implies that any indicator of health 
expectancy either for men or women, at age 15 or 65, increases in the same proportion 
as life expectancy for any gender and age, thus keeping constant the ratio between HE 
and LE. The second assumption implies that HE increases by the same number of years 
as LE does, thus implying that any gain in life years is free of health and disability 
problems. These two scenarios, which we would not properly call projections, would 
likely capture the lower and upper trends one could expect concerning future advances 
in healthy life expectancies. The results for EU countries present in the ECHP (except 
Luxembourg) are shown in Tables 14 and 15, where figures for 1996 have been 
computed out of observed data, as previously discussed. As such these scenarios keep 
on average the country differences in health adjusted life expectancies observed in the 
1990s (1994-1998). 
                                                 
6 ECHP waves 1999 and 2000 have not been taken into account for these projections to avoid excessive 
attrition in the data pooling. 64 | AHN, GÈNOVA, HERCE AND PEREIRA 
Table 14. Scenarios for health expectancies: Constant relative morbidity 
hypothesis
Females Age 15 Females Age 65
LE 15 F LEGH 15 F DFLE 15 F DFLES 15 F LE 65 F LEGH 65 F DFLE 65 F DFLES 65F
1996 66,03 43,77 54,77 60,65 19,26 7,69 12,45 15,20
BEL 2010 68,25 45,38 54,07 61,81 20,52 8,34 11,99 15,94
2025 69,80 46,41 55,30 63,21 21,64 8,80 12,65 16,81
1996 63,80 45,90 47,24 58,60 17,80 8,27 9,41 13,96
DEN 2010 65,56 47,45 47,99 59,85 19,04 8,93 9,96 15,25
2025 67,09 48,57 49,11 61,26 20,07 9,41 10,50 16,08
1996 65,42 27,88 39,29 58,52 18,59 2,92 7,34 14,35
GER 2010 67,81 29,49 40,05 60,66 20,12 3,28 7,13 15,40
2025 69,35 30,16 40,96 62,04 21,26 3,47 7,53 16,27
1996 66,14 47,28 55,77 61,61 18,59 5,58 11,82 15,26
GRE 2010 68,09 47,15 55,95 62,87 20,02 5,42 12,02 16,22
2025 69,59 48,19 57,18 64,26 21,16 5,73 12,70 17,15
1996 67,26 40,39 53,79 62,46 19,91 5,13 11,08 16,39
SPA 2010 68,97 40,60 54,16 63,49 21,04 5,31 11,49 16,93
2025 70,10 41,27 55,05 64,53 21,86 5,52 11,93 17,58
1996 67,52 35,97 48,57 59,24 20,66 5,26 8,55 14,81
FRA 2010 69,75 37,34 50,69 60,61 22,04 5,68 9,57 15,44
2025 71,34 38,19 51,84 61,99 23,15 5,97 10,06 16,23
1996 64,22 49,04 52,84 61,01 17,31 8,34 10,40 14,99
IRE 2010 66,52 51,01 54,09 63,38 19,07 9,66 11,46 16,66
2025 68,27 52,35 55,51 65,04 20,34 10,31 12,22 17,77
1996 67,15 34,75 55,92 62,48 19,87 3,21 11,91 16,06
ITA 2010 69,05 35,75 55,80 63,26 21,06 3,65 11,69 16,30
2025 70,51 36,50 56,97 64,59 22,17 3,84 12,31 17,15
1996 65,92 44,61 48,43 59,59 19,03 8,12 10,58 15,51
NET 2010 67,57 45,49 49,01 61,14 20,14 8,75 10,73 16,25
2025 69,11 46,53 50,13 62,53 21,25 9,24 11,32 17,14
1996 64,38 27,53 47,31 57,06 17,67 1,34 8,45 13,15
POR 2010 66,39 28,35 48,86 59,10 18,78 1,49 9,25 14,15
2025 68,19 29,12 50,18 60,70 20,05 1,59 9,88 15,11
1996 65,04 42,26 56,08 18,32 9,04 13,91
UK 2010 67,18 44,11 57,25 19,70 9,62 14,29
2025 69,06 45,34 58,85 21,10 10,31 15,30
Males Age 15 Males Age 65
LE 15M LEGH 15M DFLE 15M DFLES 15M LE 65M LEGH 65M DFLE 65M DFLES 65M
1996 59,48 45,34 50,63 55,71 14,96 7,55 9,71 12,52
BEL 2010 62,76 47,63 52,25 58,35 16,78 8,53 10,63 13,91
2025 64,79 49,17 53,94 60,24 18,10 9,20 11,46 15,00
1996 58,72 46,49 48,14 55,33 14,35 8,20 8,83 12,09
DEN 2010 61,53 48,83 50,20 58,36 15,95 8,89 10,03 13,71
2025 63,43 50,34 51,76 60,17 17,18 9,58 10,80 14,77
1996 59,17 29,41 37,77 53,71 14,87 2,98 4,59 11,30
GER 2010 62,21 31,97 39,71 56,61 16,57 3,64 4,95 12,73
2025 64,20 32,99 40,98 58,43 17,87 3,93 5,34 13,73
1996 60,95 47,49 52,83 57,20 16,15 6,00 10,34 13,60
GRE 2010 63,48 48,57 53,76 59,07 17,53 6,25 10,59 14,27
2025 65,39 50,03 55,37 60,85 18,82 6,71 11,36 15,32
1996 60,14 41,01 51,00 56,59 16,08 5,65 10,58 13,80
SPA 2010 61,70 41,51 51,50 57,73 16,82 5,81 10,56 14,35
2025 63,27 42,57 52,81 59,20 17,77 6,14 11,16 15,16
1996 59,73 37,18 45,74 53,35 16,12 5,35 7,38 11,69
FRA 2010 62,43 38,75 47,96 55,55 17,65 5,74 8,42 12,79
2025 64,44 40,00 49,50 57,33 18,84 6,12 8,99 13,65
1996 58,90 47,85 50,33 56,75 13,83 8,30 9,59 12,69
IRE 2010 61,44 49,71 51,47 58,88 15,36 8,85 10,08 13,79
2025 63,36 51,26 53,07 60,72 16,67 9,61 10,94 14,96
1996 60,77 37,02 52,59 57,78 15,71 3,64 10,12 13,38
ITA 2010 63,20 38,41 53,62 59,51 17,30 3,98 10,75 14,38
2025 65,24 39,65 55,35 61,43 18,66 4,29 11,59 15,50
1996 60,34 45,45 48,38 56,18 14,75 7,36 9,39 12,36
NET 2010 62,59 47,41 49,50 58,31 16,23 8,49 9,96 13,72
2025 64,31 48,72 50,86 59,91 17,43 9,12 10,70 14,74
1996 57,06 31,13 44,88 51,58 14,19 2,04 7,41 10,69
POR 2010 59,76 32,22 46,80 54,00 15,25 2,27 8,24 11,74
2025 61,97 33,41 48,54 56,00 16,55 2,46 8,94 12,74
1996 60,03 43,62 52,74 14,85 9,59 11,49
UK 2010 62,59 45,24 54,61 16,26 10,02 12,23
2025 64,45 46,58 56,23 17,54 10,82 13,20  
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Table 15. Scenarios for health expectancies: Constant absolute morbidity hypothesis 
Females Age 15 Females Age 65
LE 15 F LEGH 15 F DFLE 15 F DFLES 15 F LE 65 F LEGH 65 F DFLE 65 F DFLES 65F
1996 66,03 43,77 54,77 60,65 19,26 7,69 12,45 15,20
BEL 2010 68,25 46,15 54,55 62,03 20,52 9,11 12,53 16,23
2025 69,80 47,70 56,10 63,58 21,64 10,23 13,65 17,35
1996 63,80 45,90 47,24 58,60 17,80 8,27 9,41 13,96
DEN 2010 65,56 47,79 48,31 59,96 19,04 9,58 10,55 15,50
2025 67,09 49,33 49,85 61,50 20,07 10,60 11,57 16,52
1996 65,42 27,88 39,29 58,52 18,59 2,92 7,34 14,35
GER 2010 67,81 30,78 40,99 60,90 20,12 4,49 8,07 15,74
2025 69,35 32,32 42,53 62,44 21,26 5,63 9,20 16,87
1996 66,14 47,28 55,77 61,61 18,59 5,58 11,82 15,26
GRE 2010 68,09 47,74 56,29 63,02 20,02 6,46 12,59 16,49
2025 69,59 49,25 57,79 64,52 21,16 7,60 13,73 17,63
1996 67,26 40,39 53,79 62,46 19,91 5,13 11,08 16,39
SPA 2010 68,97 41,28 54,52 63,62 21,04 6,15 11,99 17,15
2025 70,10 42,41 55,65 64,75 21,86 6,96 12,81 17,96
1996 67,52 35,97 48,57 59,24 20,66 5,26 8,55 14,81
FRA 2010 69,75 38,35 51,28 60,89 22,04 6,67 10,33 15,84
2025 71,34 39,94 52,87 62,48 23,15 7,78 11,45 16,96
1996 64,22 49,04 52,84 61,01 17,31 8,34 10,40 14,99
IRE 2010 66,52 51,55 54,53 63,49 19,07 10,49 12,13 16,87
2025 68,27 53,30 56,27 65,23 20,34 11,76 13,40 18,14
1996 67,15 34,75 55,92 62,48 19,87 3,21 11,91 16,06
ITA 2010 69,05 36,70 56,18 63,42 21,06 4,73 12,27 16,59
2025 70,51 38,16 57,63 64,88 22,17 5,83 13,38 17,70
1996 65,92 44,61 48,43 59,59 19,03 8,12 10,58 15,51
NET 2010 67,57 46,02 49,45 61,29 20,14 9,34 11,22 16,45
2025 69,11 47,55 50,99 62,83 21,25 10,45 12,33 17,56
1996 64,38 27,53 47,31 57,06 17,67 1,34 8,45 13,15
POR 2010 66,39 29,41 49,35 59,30 18,78 2,37 9,74 14,39
2025 68,19 31,21 51,14 61,10 20,05 3,65 11,01 15,66
1996 65,04 42,26 56,08 18,32 9,04 13,91
UK 2010 67,18 44,84 57,57 19,70 10,32 14,67
2025 69,06 46,71 59,44 21,10 11,72 16,06
Males Age 15 Males Age 65
LE 15M LEGH 15M DFLE 15M DFLES 15M LE 65M LEGH 65M DFLE 65M DFLES 65M
1996 59,48 45,34 50,63 55,71 14,96 7,55 9,71 12,52
BEL 2010 62,76 48,42 52,80 58,58 16,78 9,42 11,29 14,22
2025 64,79 50,45 54,83 60,61 18,10 10,73 12,61 15,53
1996 58,72 46,49 48,14 55,33 14,35 8,20 8,83 12,09
DEN 2010 61,53 49,39 50,70 58,50 15,95 9,56 10,59 13,92
2025 63,43 51,30 52,61 60,41 17,18 10,80 11,82 15,16
1996 59,17 29,41 37,77 53,71 14,87 2,98 4,59 11,30
GER 2010 62,21 33,40 40,77 56,88 16,57 4,92 6,11 13,11
2025 64,20 35,39 42,76 58,87 17,87 6,23 7,41 14,41
1996 60,95 47,49 52,83 57,20 16,15 6,00 10,34 13,60
GRE 2010 63,48 49,14 54,12 59,24 17,53 7,08 11,10 14,51
2025 65,39 51,04 56,03 61,15 18,82 8,36 12,38 15,80
1996 60,14 41,01 51,00 56,59 16,08 5,65 10,58 13,80
SPA 2010 61,70 41,97 51,74 57,82 16,82 6,29 10,83 14,46
2025 63,27 43,54 53,30 59,39 17,77 7,24 11,79 15,41
1996 59,73 37,18 45,74 53,35 16,12 5,35 7,38 11,69
FRA 2010 62,43 39,74 48,56 55,84 17,65 6,71 9,18 13,19
2025 64,44 41,75 50,57 57,84 18,84 7,90 10,37 14,38
1996 58,90 47,85 50,33 56,75 13,83 8,30 9,59 12,69
IRE 2010 61,44 50,20 51,89 58,99 15,36 9,48 10,59 13,94
2025 63,36 52,12 53,81 60,91 16,67 10,79 11,89 15,24
1996 60,77 37,02 52,59 57,78 15,71 3,64 10,12 13,38
ITA 2010 63,20 39,35 53,98 59,65 17,30 5,18 11,34 14,64
2025 65,24 41,39 56,02 61,69 18,66 6,53 12,69 15,99
1996 60,34 45,45 48,38 56,18 14,75 7,36 9,39 12,36
NET 2010 62,59 47,92 49,94 58,45 16,23 9,14 10,49 13,94
2025 64,31 49,64 51,66 60,17 17,43 10,34 11,69 15,13
1996 57,06 31,13 44,88 51,58 14,19 2,04 7,41 10,69
POR 2010 59,76 33,28 47,30 54,22 15,25 3,01 8,64 11,94
2025 61,97 35,50 49,52 56,44 16,55 4,30 9,93 13,23
1996 60,03 43,62 52,74 14,85 9,59 11,49
UK 2010 62,59 45,94 54,93 16,26 10,56 12,58
2025 64,45 47,79 56,79 17,54 11,84 13,87  
Source: Own computations based on data from the ECHP. 66 | AHN, GÈNOVA, HERCE AND PEREIRA 
 
6.6  Education: The key to better future health status of population 
The previous exercise of building HE scenarios based on rather crude hypotheses, 
avoided the shortcomings that using observed trends would have otherwise caused. But 
even if limiting the extent of our ignorance on this matter it is still unsatisfactory. In 
order to exploit further the information contained in the ECHP to advance in this 
direction, we recall the analysis previously made on education and health as a very 
convenient way to establish some estimates about the composition effects of a more 
educated population on the future health status of EU members’ populations 
As better educated younger generations replace older generations with lower levels of 
education, the health status of the population would improve in the future. The 
magnitude of the improvement will depend on the differences in education levels 
between generations and the differences in health status by education levels. 
Given that most individual’s education levels do not change after age 30, we can project 
the educational composition of the future population for those who are currently 30 
years or older. Assuming that the mortality rate is the same regardless of education 
level, the educational composition of the population in age ‘X’ ten years from now will 
be the same as that of the population in age ‘X-10’ now. Multiplying the health status 
by age and education with the age-education distribution of the future population, we 
obtain the projection of the health status of future population. We examine the future 
health status of three age groups, 55-64, 65-74 and 75-84. Assuming that the age-
education specific health status remains at the level observed in ECHP 1994, we 
examine the health status of the three age groups in 2004 and 2014. 
As seen in Table 16, the potential health improvement owing to educational 
composition is highest among the 55-64 age group and lowest among the 75-84 age 
group, irrespective of the country considered.  
There are also substantial variations among countries. With respect to the proportion in 
good health, among the population aged 55-64 it increases by 8 and 9 percentage points 
in Spain and Greece during the period 1994-2014 while it increases by only 1 
percentage point in Belgium and the Netherlands. For the age group 65-74, the 
improvement is most (5 percentage points) in Denmark while it is least (1 percentage 
point) in Portugal. Among those aged 75-84, the improvement is relative small. 
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Table 16. Proportion in good health in 1994 (observed), 2004 and 2014 (projected) in the 
EU 
Ages 55-64  Ages 65-75  Ages 75-84   
1994 2004 2014 1994 2004 2014 1994 2004 2014 
Denmark  0,648 0,683 0,698 0,549 0,572 0,599 0,455 0,472 0,490 
Netherlands  0,607 0,623 0,633 0,501 0,515 0,524 0,444 0,454 0,463 
Belgium  0,598 0,624 0,634 0,486 0,497 0,526 0,374 0,378 0,389 
France  0,479 0,517 0,529 0,374 0,386 0,415 0,257 0,264 0,278 
UK  0,617 0,642 0,659 0,506 0,520 0,540 0,435 0,442 0,457 
Ireland  0,701 0,713 0,728 0,562 0,591 0,607 0,430 0,436 0,458 
Italy  0,387 0,405 0,430 0,268 0,272 0,293 0,210 0,211 0,213 
Greece  0,542 0,583 0,633 0,364 0,372 0,400 0,208 0,211 0,219 
Spain  0,385 0,410 0,464 0,301 0,308 0,328 0,215 0,220 0,224 
Portugal  0,298 0,310 0,326 0,165 0,166 0,174 0,125 0,130 0,131 
Source: Eurostat-ECHP and own computations 
 
Similar cross-country differences can be observed in the proportion with disability; 
Spain and Greece improve most among the population group 55-64, Belgium and 
France for the 65-75 age group, and Denmark for the oldest age group as shown in 
Table 17. 
 
Table 17. Proportion with disability in 1994 (observed), 2004 and 2014 (projected) in the 
EU 
Ages 55-64  Ages 65-75  Ages 75-84   
1994 2004 2014 1994 2004 2014 1994 2004 2014 
Denmark  0,315 0,285 0,271 0,377 0,366 0,354 0,460 0,437 0,425 
Netherlands  0,373 0,363 0,356 0,440 0,432 0,426 0,519 0,511 0,503 
Belgium  0,344 0,335 0,329 0,421 0,414 0,396 0,614 0,614 0,612 
France  0,281 0,255 0,249 0,389 0,378 0,350 0,537 0,534 0,528 
UK  0,335 0,325 0,318 0,449 0,444 0,438 0,520 0,518 0,512 
Ireland  0,260 0,248 0,231 0,392 0,383 0,376 0,493 0,490 0,478 
Italy  0,322 0,304 0,280 0,444 0,441 0,427 0,580 0,584 0,581 
Greece  0,289 0,266 0,238 0,375 0,368 0,350 0,532 0,533 0,526 
Spain  0,366 0,350 0,315 0,403 0,398 0,383 0,557 0,554 0,552 
Portugal  0,423 0,413 0,401 0,489 0,488 0,478 0,563 0,561 0,561 
Source: Eurostat-ECHP and own computations 
 
These results clearly point to a general improvement of the proportion of life years lived 
in either good health or free of disability beyond the doubts that emerged when we tried 
to extend observed trends so far. Although we have not tried to estimate figures for HE 
based on this approach, we believe this is a sound way to overcome the limitations of 
the simple procedures attempted before. Moreover, the results just commented upon are 
compatible with the scenarios also discussed previously. 68 | AHN, GÈNOVA, HERCE AND PEREIRA 
7.  Living longer, working less… keeping better? 
On the basis of the comparison of the different data sets, we have concluded that 
population ageing is a process that all countries have been experiencing, with different 
degrees and starting points, since the last few decades and that will continue, given 
current trends, in the coming decades. 
Population ageing is a result of both longer average life expectancies and fewer births. 
Life expectancy has been increasing dramatically since the past 100 years, and this has 
been compatible with both the expansion (more and more people reaching extreme 
ages) and the compression (more and more people surviving at all ages) of mortality. 
Nevertheless, in the last three decades, compression of mortality has been dominant in 
the process of population ageing rather than expansion for most countries. Expansion on 
the other hand, means a higher limit for the human life if strictly defined, which is not 
the case being observed. Relatively few people reach extreme ages, which with only 
rare exceptions surpasses 110 years of age, while the share of survivors (for a given 
generation) at 80, for instance, have typically increased from 30% to 60% or more in the 
last 30 years. 
Life-course indicators have allowed us to document, with varying accuracy for different 
countries, a general trend in the EU towards longer years in school, delayed entrance to 
the labour market, delayed emancipation from the parental home, delayed household 
formation and first parenthood, earlier retirement and longer post-retirement spans. 
Some of these trends, as it is well known, clash with each other as is the case of shorter 
working lives and longer post-retirement spans. 
Morbidity (health status or disability) puts a check on the quality with which longer 
lives can be lived. Data on these issues have not yet been comprehensively analysed 
owing to the rarity and lack of homogeneity of health and disability surveys in different 
countries. Nevertheless, the ECHP has allowed us to document health and disability 
status and to use this information to compute adjusted life expectancies either for years 
lived in good health or free of disability. Although some indications for several 
countries point to the fact that longer lives do not necessarily mean that these are lived 
in better health or with a lower prevalence of disabilities, when the recent past is 
analysed with the ECHP data, in general, we can establish a trend whose projection 
forward implies greater proportions of increased post-retirement or adult lives lived 
either in better health or free of disability. Health and disability status is, however, self-
reported and this makes data fraught with problems and hard to compare among 
countries. We have shown that using the ECHP data requires being extremely careful as 
to making country comparisons on this matter. 
All in all, European countries have had, since the mid-past century, what van de Kaa has 
termed a “second demographic transition” concerning the evolution of fertility and 
mortality. It is not easy to say whether the absolute limit to a human life has increased, 
but what is more than certain is that survival at high or even extreme ages has 
experienced a dramatic increase in the last few decades in Europe. Not less dramatic is 
the change in lifestyles and behaviours, if we trust the life-course indicators that warn us 
about the possibility of unsustainable combinations of trends, which will have to be 
contained before society discovers too late that liabilities are much higher than assets of 
any kind. Activity seems to be the most abundant and most wasted resource in Western BIO-DEMOGRAPHIC ASPECTS OF POPULATION AGEING | 69 
countries, whereas health and disability problems seem to be checked as post-retirement 
life spans increase, although not everywhere. 
Population ageing will continue in the future even at an accelerated speed, at least when 
defined in the rather strict manner in which we customarily define it (age 65 and over). 
Health and disability limitations are likely to advance less rapidly than age, thus 
allowing expectations for healthier life, but this is not necessarily to be taken for granted 
as the available data still lacks enough conclusiveness. Despite the enormous 
advancement in health in developed countries, the process of ageing critically exposes 
people to new forms of morbidity. Perhaps some future day we could speak of a ‘third 
demographic transition’ in Europe (and everywhere), which includes a more balanced 
equilibrium between age spans within the life cycle, healthier lifestyles, more active and 
less-dependent life in old age and improved options as for the transition from work to 
retirement.  
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Annex 1. Structure of the database within WP1 
of the AGIR project 
  5 Areas  Files (.xls)  Detail 
Births (all countries in one file)  Gender, year 
Historic population (one file for each country)  Age, gender, year  Population 
Projections (one file for each country)  Age, gender, year 
Mortalities (one file for each country)  Age, gender, year 
Mortality  Survivors (life tables, one file for each 
country)  Age, gender, year 
Longevity  Longevity indicators (all countries in one file)  Gender, year, country, category (up 
to 5 categories) 
Life-courses  Life-course indicators (all countries in one file)Gender, year, country, category (up 
to 11 categories) 
AGIR-WP1 
DATABASE 
Morbidity  Morbidity (one file for each country)  Age group, gender, year, category 
(up to 3 categories), grade 
Sources: National sources, www.mortality.org, REVES, Eurostat, ECHP, WHO and OECD. 
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